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Diabetes mellitus is one of the most common endocrine diseases in the 
world that affects almost 6% of the world population. The treatment of diabetes 
mellitus takes three main forms. First, diet and exercise. Secondly, insulin therap 
and thirdl , using hypoglycaemic agents (sulphonylureas and biguanides). Many 
of these agents are not ery effecti e in lowering glucose level in diabetic patients 
and are either too expenslve or have undesirable side effects and 
contraindications. As a result of this, the search for effective drugs for the 
treatment of diabetes mellitus continues 
Before the introduction of insulin in 1922, the treatment of diabetes mellitus 
relied heavily on initiatives derived from folk medicine. These initiatives include 
the use of traditional plants therapies. Many traditional plants treatment for 
diabetes exist but few have received scientific or medical scrutiny. 
The use of traditional plants for the treatment of diabetes mellitus is widely 
practiced in the Middle East. In UAE many traditional plants are used as anti­
diabetic remedies, such as the leaves of Maza stricta (Al Harmal), Tephrosia 
apollmea (Dhafra), Zygophyllum simplex (Al hifm), Moringa peregrina (Shoo), 
Ziziphus spina-cristi (Al seder), Citrullus colocynthis (Handal) and Teucrium 
mascatense (Jaadah). In spite of the wide use of these herbs to treat diabetes, no 
laboratory investigations have been conducted to determine the accuracy of the 
claims about their anti-diabetic effects. 
The aim of this study was to examine the efficacy of these plants in the 
treatment of diabetes mellitus. The aqueous extracts of these plants were 
incubated with pancreatic fragments to determine whether they have the ability to 
stimulate insulin secretion. Aqueous extracts of Citrullus colocynthis, 
Zygophyllum simplex and Tephrosia apollinea stimulated insulin secretion 
significantly in vitro. However, only Citrullus colocynthis was able to stimulate 
insulin release in a consistent manner. 
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The oral admirustratIon of aqueous ex1ract of Itrullus colocynthl seeds 
\ as mvestigated for its effects on biochemical and metabolic parameters of 
normal and streptozotocin (STZ)-induced diabetes rats. The results of this study 
re ealed that oral administration of the aqueous extract of the seed significantly 
reduced blood glucose Ie els in normal and diabetic rats in a dose-correlate 
manner. Moreover, aqueous extract of Citrullus colocynthis seeds increased 
plasma insulin level. In addition, C. colocynthis appeared to induce a significant 
increase in the number of insulin-secreting cells after induction of diabetes islets. 
There is strong indication that aqueous Citrullus colocynthis significantly 
decreased the percentage distribution of glucagon secreting cells. However, the 
treatments of aqueous extract of C. colocynthis did not completely normalize these 





I. THE PA N C R EA S  
The pancreas IS a pinkish-\\ lute organ: located retroperitoneally on the 
posterior wall of the abdominal cavity (Fig. 1 ) at the Ie el of the second and third 
lumbar vertebrae (Bockman. 1986). The pancreas of the adult human lies below 
the stomach and extend from the loop of the duodenum to the spleen (KJoppel, 
1998). The gland is highly lobulated and the outlines of the larger lobules can be 
seen b _ the naked eye (Bockman, 1986). It is Invested by connecti ve tissue that 
provides the septation to produce these macroscopic lobules. Each one of these 
lobules is composed of many microscopic lobules, called acini, which are 
considered as functional units of the exocrine pancreas (Bockman, 1986). The 
pancreas contains about 105 to 106 islets that are scattered throughout the 
parenchymal tissue. These islets are not uniform in size (KJoppel, 1998). 
The pancreas is commonly described as having a head, neck, body and tail. 
The head remains to some extent divisible structurally and functionally. The neck 
IS thinned front-to-back; the splenic and superior mesenteric veins unite 
posteriorly to the neck of the pancreas forming the portal vein. The body 
continues as the main part of the gland towards the left and blends without a 
distinct boundary into the tapering tail, wllich terminates bluntly adjacent to the 
spleen. The substance of the gland is penetrated by numerous vascular structures, 
both by those supplying the gland proper and those passing to other locations 
(Bockman, 1986). 
The pancreas is an organ of both exocrine and endocrine functions. The 
exocrine pancreas secretes enzymes and bicarbonate, wllich affect digestion and 
absorption of foods and the endocrine pancreas secrete hormones, which regulate 
the glucose metabolism. Because of these endocrine and exocrine functions, the 
pancreas is one of the most important and complex organs involved in the 
assimilation of food (Owang, 1993). 
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Figure 1. Shows the location of the pancreas in the abdominal cavity (Rhoades 
and Pflanzer, 1992) 
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The major role of ctigestlve enzymes produced by exocnne pancreas IS the 
processmg of ingested foodstuffs and then it "ill be ready for absorption. 
Whereas hormones of the endocrine pancreas play important role in the 
metabolism of every other aspects of ceUular nutrition from rate of absorption of 
foodstuffs to cellular storage (Greenspan, 1997). 
1.1 . E n d ocri n e  pan c reas 
In all mammalian species, the islets account for 1 to 2 % of the volume of 
the pancreas and a typical islet is composed of about 5,000 endocrine cells 
(Williams & Goldfine, 1993). The islets of Langerhans are not uniform in size 
and may contain few dozens, hundreds or thousands of cells. The islets constitute 
only 2% of the pancreas, but 20% of the intrapancreatic blood flow is directed 
toward the islets (Lifson et al. , 1980, Lifson et al., 1985). Because of that the 
islets are well vascularized. In the presence of high glucose levels, blood flow to 
the islets is further increased (Jansson and Hellerstrom, 1983). 
The larger islets are located near the larger blood vessels that bypass the 
surrounding exocrine tissue. On the other hand, the smaller islets are located near 
smaller arterioles that pass through the exocrine tissue and forms an 
intrapancreatic portal circulation (Bonner Wier and Orci, 1982). This type of 
circulatory arrangement exposes many peri insular acini to extremely high level of 
insulin. Therefore, the pancreatic acinar cells are the first target cells subjected to 
insulin action after release from the islets. The priority is for the microcirculation 
of the islets, through which insulin is carried to alpha, delta and polypeptide-cells 
to exert direct effects on these cells (Bonner Wier, 1988). In the islets of 
Langerhans there are four different hormone-secreting cells containing insulin, 
glucagon, somatostatin and pancreatic polypeptide. 
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I.l.a. AJ P ha cells 
Glucagon secreting cells or alpha cells form 1 5-20% of the total endocrine 
mass and contain typical secretory granules with an electron-dense core and pale 
peripheral mantle (Orci et al., 1983). These cells contain glucagon, a 29-amino 
aCId peptide, and its hyperglycemic action was discovered in 1923 (Murlin et al., 
1 923). Glucagon stimulates the breakdown of glycogen in the liver resulting 
primaril, in an increase in the level of sugar in the blood via a cyclic adenosine 
monophosphate (cAMP) mediated signal. The signal is initiated by the bind111g of 
the glucagon with its receptor on liver parenchymal cells (Unger and Orci, 1981a 
198 1 b; Unger, 1983). 
I.l.b.  Beta cells 
Beta cells (B) of the pancreas form 60-80% of the total endocrine cell mass. 
These cells contain insulin. The name of insulin is derived form the Latin word 
, insula', \ hich means island. The hormone was first isolated in 1920 to 192 1 ,  and 
its crude form was used in the treatment of diabetics (Banting and Best, 1922; 
Bliss, 1 982). 
Beta cells store up to 1 3000 of secretory granules, some fuse with the 
plasma membrane and after appropriate secretory stimulation and releases their 
content into the extracellular space (Howell, 1 984; Orci et al., 1 986). Beta cells 
contain two types of secretory granules as revealed by electron microscopy. The 
more abundant type of these granules consists of a crystalline core surrounded by 
a halo and a clearly defined limiting membrane. They are scattered within the 
cytoplasm. 
The other type of granules is less abundant and is found close to the Golgi 
apparatus. These granules have a homogeneous core, surrounded by a membrane 
coated e>.'temally with bristles consisting of the protein, clathrin. The techniques 
of electron microscope show that the coated granules contain high levels of 
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promsulUl, \v1th small amount of cleaved insulin. Because of tlus it is considered 
1IT1inature granules. In contrast, the non-coated granules contam mostly insulin 
and therefore considered as mature granules (Orci et al., 1 98 7) 
l.1.c .. Delta cells 
The Delta or somatostatin-secreting cell forms 5-10% of the endocrine cell 
mass. The cell forms a long, slender cell processes rich in secretory granules 
which end with a knob-like structure in the pericapillary space (Grube and Boho, 
1 983). Somatostatin suppresses the secretion of both effects on the secretion of 
both insulin and glucagon Somatostatin is released by delta cell in response to 
nutrients and hormones (Bloom and Plolak, 1 98 7 ;  Arimura and Fishback, 1 98 1 ). 
The first isolation of somatostatin was from the hypothalamus, but now it is 
known that it is produced by neurons and endocrine cells in many sites in the 
body (Pickup and Williams, 1 997). Delta cells of pancreas, like that of the gut 
produces somatostatin, but can be distinguished morphologically by apical or 
basal elongations, which project on to adjacent cells or capillaries and may 
release somatostatin at their terminals (Larsson et al. 1 979). 
1.1.d. Pancreatic polypeptide cells 
Pancreatic polypeptide-secreting cells (PP) form 3-6% of the endocrine cell 
mass. They contain the polypeptide of 36-amino acid. The peptide was first 
discovered as a contaminant of insulin preparation There are two 
morphologically different types of PP-cells. The ventrally cells are derived from 
pancreatic head contain round to angular secretory granules (formerly called F 
cells). The second cells derived form the dorsal part contains small granules 
(Pickup and Williams, 1 997; Kovacs and Asa, 1 998). 
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1.2. I n s u l i n  
I.2.a. Insulin Structure 
Insulin is a big protein that has a molecular weight of 5 ,808 KD (Montague. 
1 993). The protein is formed from two polypeptide chains, A and B. The two 
chains are li nked together by two disulphide bonds. Also, A chain contains an 
intrachain disulphide bond which l inks between amino acid residues 6 and II. 
The A chain consists of 2 1  amino-acid residues whi le  B chain consists of 30 
amino-acid residues (Pickup and Wil l iams, 1 997). 
I.2 . b. Insulin synthesis 
In the human, the control of the energy metabolism and glucose is highly 
dependent on the hormones secreted by islets of Langerhans. The most important 
hormone is insul in (Owerbach et al., 1 980). The encoded insulin mRNA is 
translated into preproinsul in, a 1 1 0 amino acid peptide, which contains a signal 
sequence made of 24 amino acids. In the endoplasmic reticulum, the polypeptide 
is cleaved into proinsul in (Orc i  et ai. ,  1 987;  Davidson et ai. ,  1 988). In the Golgi 
bodies, proinsulin is packaged processed into mature insul in and stored in coated 
secretory vesicles. The secretory vesicles are released from the trans-face of the 
Golgi apparatus (Orci et al., 1 987; Davidson et al., 1 988), by two enzymes whose 
cDNA were recently cloned (Smeekens and Stiener, 1 990; Seidah et al . ,  1 99 1) .  
One is trypsin-l ike enzyme which removes the intervening C peptide by cutting at 
two dibasic amino acid sequences, and the other enzyme is a carboxypeptidase B­
l i ke enzyme which removes the dibasic peptide from the carboxyl terminal end 
(Smeekens and Stiener, 1 990; Seidah et al., 1 99 1 ). The mature insulin is a 
polypeptide of 5 1 -amino acids. The peptide consists of A and B polypeptide 
chains that are l inked by two disulfide bonds at positions A 7 to B7 and A20 to 
B 1 9  (Orci et ai., 1 98 7). 
The biosynthesis of insulin is regulated by several hormones and nutrients, 
most notably by glucose. The synthesis of insulin increases after exposure of the 
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p cell to glucose In vitro (Welsh et al., 1 986; German et al. 1 990). In order for 
glucose to exert Its effects on insulin secretJon and synthesis it must first get into 
the cell. This accomplished through a process of facilitated diffusion, which is 
mediated b a glucose transporter (Bell et al., 1 990). 
1 .2.c. Insulin secretion 
In normal adults, the human pancreas secretes about 40-50 unit of insulin 
per day. The basal Ie el of insulin concentration in fasting blood sample is about 
1 0 �U/mL. After standard meals, insulin will arise above 1 00 �U/mL. The 
peripheral insulin concentration begins to increase (8-10 min) after ingestion of 
food. Then insulin will reach the peak concentration within 30-45 min. This is 
followed by decline in post-prandial plasma glucose level (Greenspan and 
Gardner, 200 1 ). 
The beta cells are poised to sense glucose to accomplish the moment-to­
moment adaptation of insulin secretion to blood glucose fluctuations. This is 
possible through particular expression profiles of carbohydrate transporters and 
enzymes in the beta cell (Newgard and McGary, 1995; Matschinsky, 1 996). 
There are three main important molecular characteristics of glucose metabolism 
by the beta cells. In the first one glucose equilibrates across the plasma 
membrane, as observed in hepatocytes, because both cell types express high 
capacity, low affinity glucose transporter (Newgard and McGary, 1 995). 
There are five types of facilitative glucose transporters. These transporters 
have been termed GLUT 1 ,  GLUT2, GLUT3, GLUT4, and GLUTS. GLUTI is 
present in all tissue of human. This transporter has a very high affinity for 
glucose. Because of this, it can transport glucose at relatively low concentrations. 
On other hand, GLUT2 has low affinity for glucose and transports when plasma 
glucose is high. This transporter is the major transporter of glucose in pancreatic 
and hepatic cells (Greenspan and Gardner, 2001)' In human beta cells, GLUTI 
dominates and GLUT2 is moderately expressed (De Vos et al. , 1995). 
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Second!. , phosphorylation of glucose to glucose-6-phosphate is catalysed 
by rugh K 1 hexokinase IV called glucokmase (GK) that constitutes the fllDC­
deterrruning step for gl colysis ( Iynedj ian� 1 993 · De Vos et a1., 1 995). Thirdly 
the pyru ate generated b gl colysis is channelled to the mitochondria In fact 
more than 90% of glucose carbons that enter beta cell  are converted to CO2 in the 
mitochondria (Schuit et aI. ,  1 997). The concentration of lactate dehydrogenase 
( L D H )  IS extremely low in the beta cell. This enzyme catalyzes the conversion of 
pyruvate to lactate. In the native beta cells, pyruvate and lactate are not insulin 
secretagogues· this is due to the low activity of monocarboxylate in the plasma 
membrane (Sekine et a1.,  1 994; Ishihara el al . ,  1 999). Pyruvate enters 
mitochondria and provides substrate to the Krebs cycle or tri carboxyli c acid 
(TCA) cycle The c cle generates ATP and other mitochondrial factors that 
promote insulin secretion (Maechler et a1., 1 998 ; Kennedy et a1 . ,  1 998). 
The intracellular second messenger Ca2+ is the crucial trigger for the 
exocytosis of insulin ( Wollheirn and Sharp, 1 98 1 ;  Wollheim et a1., 1 996). In the 
cytosol, concentration of ionised ci+ is raised by glucose. The increased TCA 
cycle activity leads to the production of coenzymes in form of NADH+H and 
F ADH2 in the matrix of mitochondria (Pralong et al., 1 990, 1 994; Duchen et al., 
1 993). The reduced coenzymes transfer their hydrogen ions in form of electrons 
and proton to the electron transport chain, which also receives electrons from the 
glycerol phosphate shuttle (Newgard and McGary, 1 995 ; Eto et al., 1 999). 
There are two consequences, fIrstly, ATP is generated and transferred to the 
cytoplasm (Maechler et al., 1 998). Secondly, the potential of the membrane 
across the inner mitochondrial membrane is hyperpolarised, becoming more 
negative inside (Duchen et al., 1 993 ; Maechler et al., 1 997). The above 
coenzymes lead to an increase in the level of cytosolic ATP or rather the ATP : 
A D P  ratio (Matschinsky, 1 996; Detimary et aI. ,  1 998). The high level of 
cytosolic ATP causes closure of the ATP-sensitive K
+ (K A1P) charmels. The 
closure of K
+ channels leads to depolarisation the plasma membrane and 
initiation of typical electrical activity (Dean and Mtthews, 1 968). The 
depolarization evokes the opening of voltage-sensitive Ca
2+ c hannels (Horvath et 
al., 1 998; Ligon et aI . ,  1 998 ). 
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I.2.d. Insulin action 
The carboh drate metabolism is regulated by several hormones and by the 
activity of the sympathetic and parasympathetic divisions of the autonomic 
nervous s stem (McGuinness et al . ,  1 993; Cersosimo et al . ,  1 994). The tight 
homeostatic control of the glucose range is governed by the bal ance between the 
glucose absorption from the intestine, and production of glucose by the Ii er and 
theu uptake and metabolism b peripheral tissues (Saltiel and Ka.hn, 200 1 ). 
I nsulin IS the primary regulator of blood glucose concentration. The regulatory 
action of insulin is manifested through enhancing effects on glucose uptake by 
muscle and adipose tissues, and through its inhibiting effects on hepatic glucose 
p roduction (Saltiel and Khan, 200 1 ). 
Also, insulin promotes the storage of glucose in fat, liver and muscle by 
stimulating l ipogenesis, glycogen and protein synthesis, and inhibiting l ipolysis, 
glycogenolysis and protein breakdown. Insulin also stimulates cell growth and 
differentiation (Michael et al. 2000). Therefore, insulin deficiency of resistance 
results in d sregulation of these processes, and enhance in fasting and 
postprandial glucose and lipid levels elevation (McGuinness et al . ,  1 993; 
Cersosimo et al. 1 994). 
1.3. G l u cagon 
Pancreatic glucagon is a 29 amino-acid peptide produced in A-cel ls  of the 
islet of L angerhans from proglucagon which is 1 60 amino-acids peptide and 
larger than glucagon by fi ve to six times. This precursor of glucagons undergoes 
different post-translational processing in the gut, giving rise to glucagon-like 
p eptide I (GLP- 1 )  and other p roducts (Habener et al. ,  1 99 1 ; Holst et al . ,  1 99 1 ;  
Kreyman and Bloom, 1 99 1 ). 
The secretion of glucagon is regulated by nutrients, autonomic nerves and 
by both islet and gastrointestinal hormones (pipeleers et al. ,  1 985). There are 
some factors that induce glucagon release. These factors include hypo glycaemia 
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and stress-induced sympathetI c nerve acti ation Feedrng also enhance glucagon 
secretlon. The feeding effect 1S either d irect through stImulatory actions of amino 
acids and free acids on the A-cell, or indirect through the activation of meal­
parasympathetic nerve and hence the release of gastrointestinal hormones 
including GIP (Schuit and Pipeleers, 1 986; Berggren et al . ,  1 992). 
In contrast to its effect on insulin, glucose inhi bits glucagon secretion 
Ho\ ever glucagon b itself  is a powerful sti mulus to insulin secretion. The 
stimulatory effect of glucagon on B cel ls is mediated by a specific plasma­
membrane receptor of glucagon that is l inked to adenylate cyclase system that 
upon proper acti vation generates cAMP within the B cell (Van Schravendij k et al. ,  
1 985 .  Schuil and Pi peleers. 1 986. Berggren et  ill . .  1 992: Kmyaj et aL 1 995 ). The 
generation of cAMP wil l  activate P KA, which activates the secretory machinery 
o[ the B cells (McDermott Sharp. 1 994). 
Glucagon is the major factor that increases glucose output from the liver. 
Through its stimulating hepatic glycogenolysis and gluconeogenesis glucagon 
increases the level of  glucagon in the plasma. Therefore, glucagon is useful i n  the 
treatment of hypoglycaemia (McGuinness et al . ,  1 993; Cersosimo et al. ,  1 994). 
During fast ing, glucagon plays important role in sustaining proper glucose 
concentration level (Cherrington et al. ,  1 987). 
Glucagon plays an important role in  inducing hepatic glucose output, which 
largely accounts for basal hyperglycaemia in NIDDM. It  also promotes hepatic 
output of ketone bodies from fatty acid precursors (ketogenesis). Furthermore, 
through its stimulating effects on adenylate cyclase system and generation of 
cAMP, glucagon enhances glycogen breakdown (Cherrington et al. , 1 987). 
1.4. Somatostatin 
Somatostatin is present in  nerve terminals and other tissues such as the 
endocrine cells of the is lets of Langerhans and gastrointestinal tract. Within the 
islets somatostat in is released from D-cells. It consists of 1 4  amino acids, and it , 
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IS considered to be a local inhibItor of msul m  and glucagon secretion from 
adj acent A and B cel ls ( Bonner Weir. 1 99 1 ; Marks, 1 992). 
The pre-pro-stomatostatin is converted to prostomatostatin and then by 
alternative pathways to either somatotrophin-releasing i nhibiting factor (SRIF)- 1 4  
in  nerve and islet or SRl F-28 i n  the gut (Holst et al . , 1 99 1 ). The secretion o f  
smatostatin i s  regulated by nutrients, endocrine and neural factors (Reichl in, 
1 98 3 ;  Will iams and Bl oom, 1 992). The inhibitory effect of somatostatin on 
insulin secretion is associated with a decrease in the formation of cAMP, coupled 
with G-protein mediated actions on ion channels which result in membrane 
hyperpolarization and hence a decrease in the level cytosol ic  Ca2+ concentration 
(Ni lsson et al . ,  1 989; Kakei et al. ,  1 994). 
1.5. Pa n c rea tic poly peptide 
Pancreatic polypeptide (PP) is  a 36  amino-acid peptide produced by PP 
cel ls. These cel ls  are located in the head of the pancreas and also scattered 
throughout the exocrine  parenchyma Secretion of these peptides is under 
autonomic control and it is released after feed ing or during hypoglycaemia 
(Wil l iams and Bloom, 1 992). PP does not affect i nsulin, glucagon or somatostatin 
secretion (Degano et al., 1 992). PP inhibits pancreatic bicarbonate and protein 
secretion (Mulvihi l l  and Debas, 1 997). This is considered to be the major 
physiological action of the PP. I ts minor action includes relaxation of the 
gal lbladder (Mulvihi l l  and Debas, 1 997). 
1.6. Biochemical parameters 
Diabetes mel l itus causes shifts of potassium from cells into the extracellular 
space. Most of body's potassium i s  intracellular. For that, serum potassium is 
usually normal to sl ightly elevated prior to institution of treatment (Greenspan and 
S trewler, 1 997). Serum potassium levels are controlled by uptake of potassium 
i nto cel l s  renal excretion and external losses. The uptake of potassium is , 
governed by the activity of the Na+-K+-ATPase in the cell membrane and by H� 
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concentratIon. ptake of POtasSIum is stImulated by insul tn, �-adrenergic 
stImulation and by theophyl l ines (Kumar and Clark. 1 999, Greenspan and 
StTe\\. ler, 1 997). Sodium salts are the major solutes of the extracel lular fluid 
Phosphate forms an essential part of most biochemical systems, from nucleic acids 
downwards. Appro imatel , 80% of phosphate is within bone, plasma phosphate 
normal ly ranges from 0.8 to 1 .4 mmolL" l . Phosphate reabsorption from the kidney 
is decreased b '  parathyroid hormones therefore that hyperparathyroidism is 
associated with low plasma levels of phosphate. The regulation of plasma 
phosphate is l inked to calcium (Kumar and Clark, 1 999, Greenspan and Strewler 
1 997). Aminotransferases are enzymes present in hepatocytes and leak into blood 
with l iver cell damage. Usual ly two enzymes measured aspartate arninotransferas 
(AST), and alanine aminotransferase (ALT). AST is a mitochondrial enzyme. 
Also AST is present in heart, brain, kidney and muscle. High levels are seen in 
hepatic necrosis, myocardial infarction muscle injury and congestive cardiac 
fai lure. AL T is a cytosol enzyme, more specific to the l iver. So a rise in AL T level 
only occurs within the l i ver. Alkal ine phosphatase (ALP) is an enzyme present in 
canalicular and sinusoidal membranes of the l iver. Also, ALP is present in many 
other tissues, l ike bone, intestine and placenta. Any cause whether intrahepatic or 
extrahepatic disease can cause a rise in serum ALP. Gamma-Glutamyl transferase 
or r-Giutarnyl transpeptidase (OOT) is a microsomal enzyme. OOT is present in  
many tissues as wel l as the l iver. Activity of OOT can be induced by drugs, such 
as, phenytoin and alcohol .  ALP and OOT are excreted by a simi lar way. Because 
of that OOT rises in parallel with the ALP in cholestasis (Kumar and Clark, 1 999). 
The normal range of calcium levels is 2.2- 2.6 mmoIL"
I . 40% of this amount is 
ionized and physiological ly relevant. The reminder is protein-bound, especial ly 
albumin, or complexed and thus unavailable to the tissues (Kumar and Clark, 
1 999). 
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l l .  D IA BETES M E L L ITUS 
Diabetes mel l i tus I S  one of the most common endocnne diseases ill the 
world affecting almost 6% of the world population (Adeghate, 200 1 ). In 1 993 the 
World Heal th OrganizatIOn (WHO) published a standardized global estimate 
based on data from 75 communities in  32 countries for the prevalence of diabetes 
and impaired glucose tolerance in adults (King and Rewers, 1 993). In developed 
countries d iabetes complicat ions i s  considered to be one of the major causes of 
death, and avai lable e idence indicates that diabetes has reached epidemic 
proportions in rapid I developing countries (Wellborn et al . ,  1 995). 
Between 1 995 and 2025 the worldwide prevalence of diabetes wi II illcrease 
by 35%, from 4.0 to 5.4 %. The prevalence in developed countries is currently 
higher than the prevalence in  developing countries but it wi ll be same in 2025 . 
The number of adult diabetic i n  the world is estimated to increase by 1 22%, from 
1 3 5  mil l ion in  1 993 to 300 million in 2025. In the developed countries, the 
increase wil l  be about 42%, from 5 1  mill ion to 72 mil lion. But in developing 
countries, the increase wil l  be about 1 70%, [Tom 84 mill ion to 228 mill ions (King, 
et al, 1 998). 
Non-insul in diabetes mel l itus (NIDDM) in Arabian Gulf countries accounts 
for about 90% of  all cases of diabetes. More than 1 0% of the adult population has 
diabetes. lbis d isease i s  twice more common in females than in males (Taha et al . ,  
1 983 · Mahroos, 1 986; Fatani et al. ,  1 987;  Asfour et  al . ,  1 99 1 ). In  UAE, the 
prevalence of NIDDM based on hospital records that show that the magnitude of 
the problem is  at least as great as that in other Gulf States (Gamer et al . ,  1 994). 
The prevalence of NIDDM among UAE adult population is perceived as 
being raised when compared with western societies (Papworth and FaIjou, 1 998). 
NJDDM is  an important cause of disabil ity in  UAB. Recent, small survey in UAE 
reported an overall prevalence of 25% (El-mugarner et al. ,  1 995; Papworth and 
Farjou, 1 998). The prevalence of NIDDM in UAE depends on the location; in the 
rural, isolated areas it is about 7%, and about 1 4% in the sub-urban areas and 44% 
of the urban group (papworth and Frujou, 1 998). 
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DIabetes mel l I tus IS the commonest cause of blindness after the age of 40 
_ ears. kidney fai lure requiring dial sis and kidney transplantation, damaging of 
foot and leg tissues (Albert et al . ,  1 992). Also, it i ncreases the incidence of defects 
in babies born to diabetic mothers. As a result it reduces l i fe expectancy by up to 
a third. The cost of the d isease \ orldwide in terms of lost workmg hours, 
treatment cost, approach biJ I ions of dol lars (Sharma, 1 993). 
I I . I .  Defi n it ion 
Diabetes is derived [Tom Greek word '"diabainein" which means to  pass 
through, this, according to the early generation of physi cian's means the large 
quantity of ater taken orally (polydypsia) pass through the body to give 
excessive amount of urine (polyuria). Diabetes simply means excessive urination. 
This urine has a sweet taste, which enable physician to distinguish it from diabetes 
insipidus (Adeghate, 200 1 ). 
Diabetes mell itus is a heterogeneous group of disorders characterized by 
high b lood glucose levels (Pickup and Will iams, 1 997). Diabetes mell itus can also 
be defined as a chronic disease characterized by sustained hyperglycaemia 
because of absolute or relative deficiency of insulin. Absolute insulin deficiency 
caused by loss of beta cell and relative deficiency of insulin action in concert with 
inappropriate i nsulin release (WHO, Geneva 1 980). 
II.2.  C la ssification 
Diabetes mell itus can be divided into five types. Either fasting 
hyperglycaemia or elevated plasma levels of plasma glucose during an oral 
glucose tolerance test (OGTT) can characterize al l these types. These types are 
Type I ( insul in dependent diabetes mellitus; IDDM), Type I I  (non-insulin 
dependent diabetes mel litus, NIDDM), gestational diabetes mellitus, malnutrition 
related diabetes, and other types ( American diabetes Association, 1 997). 
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l l.2.a. Type I diabetes mellitus 
Type I diabetes was formally referred to as insulin-dependent diabetes. or 
juvenile-onset diabetes. This type of diabetes results from a cellular-mediated 
autoimmune destruction of the �-cells of the pancreas (Atkinson and Maclarell-
1 994; Tuttle et al , 200 1). The causes of autoimmune destruction of pancreatic �_ 
ceJls are still not clear. Also, the environmental factors which trigger the 
destruction of �-cells in genetically susceptible children, adolescents and even 
adults still not clear (Bell and Polonsky, 200 1 ). 
The rate of �-celJs destruction is variable. In some individuals It is rapid 
while in others it is slow (Zimmet et al. , 1 994). The rapid progressive form is 
observed commonl in children, but also it can occur in adults (Humphrey et al , 
1 998). On the other hand, the slowly p rogressive form also occurs in adults. In 
this type of dia betes, children and adolescents present with ketoacidosis as the 
first manifestation of the disease (Japan and Pittsburgh Childhood Diabetes 
Research Groups, 1 985). 
Other patients have modest fasting hyperglycaemia that rapidly changes to 
severe hypergylcaemia and! or ketoacidosis in the presence of infection or other 
stress. Some adults may retain residual beta-cell function, which is sufficient 
enough to prevent ketoacidosis for many years (Zimmet, 1 995 ). In Type I 
diabetes, patient depend on insulin for survival and they are at risk for 
ketoacidosis (Willis et aI . ,  1 996). At this stage of the disease, the secretion of 
insulin is low or no insulin secretion is manifested by low or undetectable levels 
of plasma C-peptide (Hother-Nielsen et al. , 1 988). 
The majority of patients in Type I diabetes are children and adolescent, but it 
can also occur in any age, ranging from childhood to the ninth decade of life 
(Verge et al., 1 996). Patients with Type I diabetes are usually not obese, but the 
presence of obesity is not incompatible with the diagnosis. Also, patients may 
have other autoimmune disorders such as Graves' disease, Hashimoto's 
thyroiditis, and Addisson's disease (Betterle et al. , 1 983). 
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I T .2 . b.Type IT diabete 
In type I I, formal l referred to as (non-insulin-dependent d iabetes mell itus). 
fat and muscle cel ls are resistance to the action of the insuli n  and this leads to 
activation of �-cel ls to secrete more insul in. This amount of insulin is not 
sufficient to maintain normal blood sugar level (Cavaghan et aI . ,  2000; Kahn, 
200 1 ). Type I I  d iabetes mel l itus has different subtypes, and each type is 
characterized by ariable degrees of insulin resistance and �-cells dysfunction, 
which all leads to hyperg\ycaemia (Bell and Polonsky, 200 1 ). 
Thi s maturity onset diabetes mel l itus is a complex disorder. It is 
characterized by insul in resistance and glucose intolerance (Garner et al . ,  1 994). 
This disease is general I associated with obesity and it is common in adults of 
more than 40 years of age (Tuornilehto et aI. ,  1 992; Nathan, 1 993) .  
Type I I  diabetes is the most common form of diabetes and one of the most 
frequent metabolic disorders world\vide (Nyomba, 1 993 ). Individual with type I I  
diabetes do not need insul in to survive. Type I I  diabetes mel l i tus is frequently 
undiagnosed for many years. This may be due to fact that the hyperg\ycaernia is 
not severe enough to cause noticeable symptoms of d iabetes. Stil l ,  these patients 
are at i ncreased risk of developing macro vascular and microvascular 
complications (Harris, 1 993 ' Mooy et al . ,  1 995). 
The majority of type I I  patients are obese. Obesity is one of the causes of 
insulin  resistance (Bogardus et al. ,  1 985;  Campbel l  and Carlson, 1 993). Others 
who are not obese by traditional weight criteria may have increased percentage of 
body fat d istributed predominantly in the abdominal region (Kissebah et ai. ,  
1 982). In type I I  diabetes, ketoacidosis is  infrequent, when seen i t  usually arises in 
association with stress such as infection (BaneIj i et aI. , 1 994; Umpierrez et aI. , 
1 995).  
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In type I I ,  i nsulin levels appear normal or ele ated, and high level of glucose 
IS expected WIth normal beta-cel l function (Polons!..")' et al . ,  1 996).  For that, insulin 
secretion is  defect! e and insufficient to compensate for the insul in resistance. 
Insul in sensiti vity can be increased by increased physical activity, weight 
reduction, and / or physiological treatment of hypergl caemia, but wi ll not be 
restored to normal (Simonson et al . ,  1 984; Wing et a t ,  1 994). The risk of the 
disease increases with age, obesity and lack of ph sical activity. It may also occur 
with prior gestational diabetes mel l i tus and in patients with hypertension or 
d. sl ipidaernia (Zimmet, 1 992; Harris et al., 1 995). 
I I .3.  Sym p tom s a n d  d iagnosis 
The diagnosis of  diabetes is promoted by symptoms such as increased thirst, 
passage of large amount of urine, mostly at night (nocturia) and sometimes 
sufficient to cause chi ldren to wet the bed (enuresis), overwhelming tiredness 
unexplained weight loss in severe cases, recurrent infections, drowsiness and 
coma· high Ie els of glycosuria are present. There are minor symptoms such as 
muscular cramps especial ly in the legs, skin infections, nausea, and vomiting 
(World Health Organizat ion, 1 985; Pickup and Wil l iams, 1 997). 
In diabetes mel l itus, severe hyperglycaemia detected under cond ition of 
trauma, acute infect ion, circulatory or other stress should not in  itself be regarded 
as diagnostic of  diabetes. In symptomatic subjects of d iabetes the diagnosis should 
never be made on the basis of a single abnormal blood sugar value. For that, one 
additional p lasmal blood glucose test result with a value in diabetic range is 
essential. The blood sample can be a fasting sample, a random sample, or a 
sample from the oral glucose tolerance test (OGTI). I f  these tests fai l  to confirm 
the diagnosis, it wi l l  usual ly be advisable to maintain surveil lance with periodic 
re-testing unti l  the diagnosis becomes clear (World Health Organization, 1 999). 
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In chi ldren, d iabetes melhtus mant fest severe s mptoms such as " ery high 
blood sugar Ie els, marked ketonuria, and glycosuria In most cases of children 
the diagnosis is confirmed WIthout dela_ by blood glucose measurements, and 
immediatel the treatment including insulm injection is initiated (McCance et a1. 
] 994). 
D.4. C o m p l ications of d ia b etes m el l i tus  
Man_ chronic metabotic d isorders are associated with diabetes mell i tus. 
These d isorders affect the metabolism of carbohydrates, protein, fat, water and 
electrolytes. These disorders lead to structural changes in the tissues of many 
systems of the body, especial ly the vascular system (Adeghate, 200 1 ). 
All forms of diabetes are characterized by chronic hyperglycaemia and 
de elopment of  diabetes specific microvascular pathology in the retina, renal 
glomerulus and the neuropathy of peripheral nerve. As a conseq uence of 
microvascular pathology, diabetes wi l l  lead to blindness, end stage renal disease 
and a variety of debi litating neuropathies (Brownlee, 200 1 ). 
Also, diabetes causes accelerating atherosclerotic macro vascular disease 
affecting arteries, supplying the heart, brain and lower extremities. Because of 
this, d iabetic patients have a higher risk of having myocardial infarction, stroke 
and l imb amputation. Large number of studies shows a strong relationship 
between glycaemia and diabetic microvascular complications in both type-I and 
type-I I  diabetes (The diabetes control and complications trial research group, 
1 993; UK prospective diabetes study, 1 998). Both insulin resistance and 
hyperglycaeroia have important roles i n  the pathogenesis of  macrovascular 
comp lications (Wei et al.,  1 998). 
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I I.S. T rea t m en t  a n d  m a n a gem ent 
PatIents with I DDM require insul in .  The usual method of treatment by 
insul in is subcutaneous injection (Pickup and Williams, 1 997). NIDDM is difficult 
to manage and often poorly or  insufficientl_ treated (Williams, 1 994). It is 
important to treat coexisting cardiovascular risk factors such as dysl ipidaemia, 
hypertension and smoking. Patients must start change their l ifestyle, especlally 
diet and increase physical exercise ( Pickup and Wil l iams, 1 997) 
The most commonly used drugs in the treatment of NIDDM are 
sulphonylureas ( insul in secretagogues) and biguanide, metforrnin. These drugs act 
"ia enhancing insulin action in  skeletal muscle and the l iver (UK prospective 
diabetes study group, 1 995 ). Sulphonylureas is more useful for non-obese patient 
with insulin deficiency as main pathologic cause but metforrnin is more 
appropriate for obese patient with marked insul i n  resistance (Lean et al., 1 989). 
M any of the patients fai l  to response to monotherap and hence, they are treated 
with a combination of drugs. If this combination fai ls. then insul in will  be 
prescribed (Gatling et al. , 1 985 ; Lean et ai . ,  1 989). Acarbose is ( inhibitor of 0.­
glucosidase i n  the gut wall). used for patients who are not controlled by 
sulphonylureas or metformin (Reaven et al., 1 990). 
New o ral hypoglycemic agents have been introduced to assist m the 
treatment of diabetic p atients. The most recent are rosiglitazone (a peroxisome 
prol i ferator-activated receptor- PP AR agoni st )  and rapid-acting i nsul in 
secretagogues such as repagl inide (Townsend, 2000). 
D iabetes mell i tus is a medical condition known for thousands of years and 
has been treated by many traditional herbs. Most of these herbal remedies are sti l l  
awaiting i ntensive i nvestigation and trial to confirm their efficacy (Pinn, 200 1 ). 
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I I I. M E D IC IN A L  PLA TS 
A medicinal p lant contains one or more chemical material in 10\\ or high 
concentration that can treat one or more of diseases. or decrease the symptoms of 
disease (E\ aus. 1 996. E I-Ghonemy. 1 993 ). 
I T ! . I .  H isto ry 
Medicines deri yed from plants hm e been a part of the human e\ olution. and 
healthcare for thousands of 'ears. Toda , about 88% of the global populations 
tum to the medicines derived from plants. These plants are considered as the first 
l ine of defense for maintaining health and combating diseases. Secondary 
metabolites of one hundred and nineteen plants derived from plants are used as 
drugs globall (Perumal Samy, 1 999). 
Considerable attention has been placed on new drug discoveries. These 
discoveries are based on traditional medicinal plant used throughout the world. 
Seyeral hundred plants in medical category, used in modem medicine and 
pharmacy (Lewis, 1 994). 
11 1.2 . C la ssifica t ion 
Medicinal p lants are arranged in  different ways according to : 
1. Alphabetical classifica tion: Either Latin or vernacular names can be used. 
Thi s  arrangement is used for dictionaries and pharmacopoeias.  Also, it is suitable 
for quick reference, but it gives no indication 0 inter-relationships between drugs 
(Evans, 1 996; EI-Ghonemy, 1 993). 
2.  Taxonomic:  The drugs are arranged according to  the plants, from which they 
are obtained, in classes, orders, famil ies, genera and species. This arrangement 
allows of a precise and orderly arrangement. It accommodates an drug without 
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amblgUlt} This system has becomes less popular for teaching purpose III 
pharmaceutJcal science (Evans, 1 996). 
3. Morphologica l :  I n  this arrangement, d rugs are divided into groups such as 
leaves, fruits, flO\ ers, herbs, entire organisms woods, barks, rhizomes and roots 
Tills is known as o rganized drugs. On the other hand, d ried lattices e "tracts, 
gums, resins, oils, fats and waxes are known as unorganized drugs. This type of 
grouping is used [or studding crude d rugs, identification of powdered d rugs that 
are based on macro-morphological properties ( Evans, 1 996; EI-Ghonemy, 1 993). 
4. Pharmacologica l  o r  therapeutic :  In this c lassification arrange d rugs are 
grouped according to the pharmacological action of their most important 
constituent or thei r therapeutic use. Despite this, it is important to appreciate that 
the constituents of any d rug may fal l  into different pharmacological groups 
( E  ans, 1 996). 
5.ChemicaJ or Biogenetic :  The most i mportant composition such as alkaloids, 
glycosides, volati le  oils, and others, or their biosynthesis pathways form the basis 
of classifi cation of the d rugs. This type is the most popular arrangement used for 
teaching of pharmacognosy. Ambiguities arise when one d rug possess a number 
of active compounds and thus belong to different phytochemical groups (Evans, 
1 996). 
l l I .3.  M ed ic i n a l  p l a n ts  a n d  the t reatm ent of d iabetes m el l i tus  
There i s  great scope for lU1derstanding the pathophysi ology of diabetes 
mel l it us due to its importance in human health. Historically, the studding of the 
pathogenesis of diabetes was i n  the traditional pattern of endocrinology (Jouad, 
2000). The treatment of diabetes mell itus takes three main forms. F irst, d iet and 
exercise. Secondly, i nsulin therapy, and thirdly, using hypoglycaemic agents 
(sulphonylureas and biguanides) Ovorra et al . ,  1 989). M any of these agents are 
not very effective i n  lowering glucose i n  diabetic patients. Also, these agents are 
either too expensive or  have undesirable side effects and contraindications 
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(Jaouhan el aI , 20 ) Because of thjs, the search for effective d rugs [or treatment 
of diabetes mel l l  tus continues (Subramoniam et al . ,  1 996) 
Since time immemorial, patients with diabetes have been treated orally \\1th 
different pJant e 'tracts. The logical wa of searchi ng for new d rugs to treat 
diabetes is to eval uate these plants, and especially their acti  e natural p rinciples 
( !vorIa et aI , 1 989). Treatment of diabetes by medicinal plants goes back to Be 
time when Papyrus Ebes ( 1 550 BC) recommended a high-fibre diet of wheat , 
ochre and grains. Today, more than 400 medicinal plants have been described i n  
the diabetes treatment (Wasfi et aI. ,  1 994). 
Many products of herbs including several metals and minerals have been 
described for the care of diabetes mellitus in ancient l iterature. The use of 
trad itional medicinal plants for diabetes mel l itus is wideJy practiced in the Middle 
East. The World Health Organization has recommended that the use of herbal 
medicine sho uld be encouraged (WHO, 1 980). In folk medicine of different 
cultures many of plants species are used for their hypoglycaernic properties. And 
therefore, it s appropriate used for the treatment of d iabetes mel l i tus (Abdel-Barry 
et aI . ,  1 997). 
There is a renewed interest i n  the use of trad itional plant for the treatment of 
diabetes mel litus, fuel led by a growing public interest and awareness of the so­
cal led complementary and natural type medicine. Before discovering insul in 
therapy in 1 922, traditional plant treatments were the cornerstone of antidiabetic 
therapies. Traditional herbal preparations continue to form the predominant 
therapeutic approach in many deprived regions of the world. But, in Asian 
societies, insul in was soon recognized as the miracle l ife-saver and traditional 
plant treatment were forgotten (Day and Bailey, 1 988).  
The severity of diabetic complications correlates wel l with the duration and 
extent of hyperglycaemia Improvement i n  the glycaemi c  control defers the l ate 
onset complication and slows their progression. I nsulin inj ection and oral 
anti d iabetic drugs (sulphonylureas, metforrnin, and acarbose) do not reinstate a 
completely normal pattern of glycaernic control, whether used alone or in 
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combination (UKPDS Group, 1 995) A search for additlonal agents to combat 
hyperglycaemia and its complications reported an operung to revisit traditional 
antIdiabetic plants (Gra and Flatt, 1 998 ). Man_ plants haye hypoglycaernic 
action in animals and hwnans (Prince et aI.,  1 998). 
Man traditional plants act at least in part via their fibre. vitamin or mineral 
content. Mineral deficiencies are common with diabetes. Supplements of mineral 
can benefit patients with mineral deficiencies, as demonstrated by the 
administration of magnesium and zinc. Plants rich in minerals can control 
glycaemia in diabetic patients (Day, 1 990). Some inorganic elements like 
potassium, zinc, calcium, manganese and traces of chromium have role in the 
improvement of impaIred glucose tolerance and their indirect a role in the control 
of diabetes mellitus are being increasingly recognized (Gurson and Saner, 1 97 1 ;  
Mertz, 1 98 1 ; Kinlaw et aI. ,  1 983·  Niewoehner et al., 1 986). 
Furthermore, zinc ions are necessary for crystallization of insulin and insulin 
is stored as a zinc complex. Also, normal concentration of potassium is necessary 
for optimal secretion of insulin. Depletion of potassium or hypokalaemia can 
result in reduced glucose tolerance. Calcium, potassium and traces of chromium 
pla_ important role in the release of insulin from cells of the islets of Langerhans 
(Underwood and Mertz, 1 986). 
Several plants have provided entirely new hypoglycaemic compounds. Many 
of these compounds are alkaloids, flavonoids and glycosides that do not lend 
themselves readily to pharmaceutical development. Also, antidiabetic medicinal 
plants are sources of agents that can benefit the co-morbid conditions of 
dyslipidaemia, hypertension or atherosclerosis (Day, 1 995). 
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U I .4.  Lo ca l m ed icina l p la n ts u sed in th is study 
1 .  Zygo phyLlum simplex: 
Scientific name: Zygophyllum simplex. 
Family n ame: Z goph. l laceae 
Local name. lIirrn, Ginn, Kharmeel (EI-Ghonemy, 1 993 ). 
Description : Annual herb spreading with prostrate branches ( Fig. 2). Leaves are 
cyl indri cal, succulent, 6- 1 8  mm. Flowers are yel low, axillary, about 5 mm across; 
pedicel elongati ng in fruit, becoming deflexed . Capsule obovoid, with 5 narrow­
\\;nged carpels, wrinkled (Ghazanfar, 1 994; Wester, 1 989). 
Distribu tion: Common in  l imestone along the Arabian Gulf l ittoral, in central 
desert area and along the east coast as wel l as foothi l ls. Rare in deep sand ; rapidly 
colonises gypseos soi ls  and locally dominant annual west of Jabal Dhanna 
(Ghazanfar, 1 994). Fairly \\>;despread in smal l groups at upper elevations; also 
plants found in desert plantations at Shwayb (Wester, 1 989). 
Medicinal uses: This plant is  used for infected swol len eyes, tumours d iabetes 
mell itus, eczema. Also used for camel d iseases. The leaves of the plant are used 
as an antibiotic and laxative (El-Ghonemy, 1 993; Saleh et al. ,  1 993 ; Rizk and EI­
Ghazaly, 1 995). 
Cbemical composition:  This plant contains alkaloids, sterols and lor terpenes, 
tannins and flavonoids that have been i denti fied as kaempferol 3-glucoside and 
q uercetin 3 ,  7-diglucoside (Hassanean and Desok)" 1 992; Ghazanfar, 1 994; Rizk 
and EI-Ghazaly, 1 995). 
Flowering and fruiting: March to June (Ghazanfar, 1 994). 
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Figure 2 :  Zygophyllum simplex: (A) Branches of Zygophyllum 
simplex. 
(B) Branches with flowers (Rizk and EI-Ghazaly, 1 995). 
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2. Tephrosia apo llin ea: 
Scientific  name: Tephro LQ apollmea 
Fami ly name: Legununosae. 
Local name: Dhafra (EI-Ghonemy, 1 993) 
Descri ption:  Perennial shrub, up to 50 em tal l .  Stem is branched. Leaves are 
imparipinnate; leaflets 2-4 * 1 .5-2 em, oblong to oblaneeolate. Flowers are 
purple, in axi llary racemes ( Fig. 3). F ruIt a pod, 3 0-40 mm wide, flattened, 6-9 
seeded, valves splitting spirally when mature (Ghazanfar, 1 994). 
Distribu tion:  Extremely common in al l foothills up to 3000 ft plus, along 
mountainous wadis and on rough alluvial plains on both sides of the Hajjar 
M ountains and locally dominant (Wester, 1 989). 
Med icinal uses: It is used for the treatment of bronchitis, cough, earache, 
wounds, piles antidotal , and for d iabetes mellitus, dyspepsia, inflammation, 
tympanitis, calculous and dry eczema It is useful in the treatment of disease of the 
heart and blood, l iver gonorrhea, tumours, pi les and ulcers. The plant is also used 
as a tonic, laxat ive, blood purifier, deobstruent ( Moss a et al . ,  1 987;  El-Ghonemy, 
1 993;  Ghazanfar, 1 994). 
Chemical composition :  Tephrosin, delguel in and quercetin, glucoside have been 
isolated i n  related species of Tephrosia. Also, the plant contains al kaloids 
flavonol, tannins, volatile oils, anthraquinones (Mossa et al., 1 987;  EI-Ghonemy, 
1 993;  Ghazanfar, 1 994). 
Flowering and fruiting: Throughout the year (Ghazanfar, 1 994) 
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Figure 3:  Tephrosia apollmea. 
(A) Whole plant (El-Ghonemy, 1 993). 
(B) Dried branches. 
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3. Rh azy a stricta: 
Scientific name: Rhazya trieta. 
Family name: Apocynaceae. 
Local name: Harmal (El-Ghonem)" 1 993). 
Description :  Perennial shrub, 30-70cm tall. o ften the base of the sterns is woody 
and co ered \vith scars of old leaves (Fig. 4). Flowers are in terminal corymbose 
cluster, arising in the axils of the leaves, white. Seeds are compressed, brovm, 
surrounded with a narrow pale brown wing (Wester, 1 989; Ghazanfar, 1 994). 
Distribition : Very common alluvial plains around AI-Ain and on gravels 
east and west of Hajjar Mountains; sometimes in ext insive clumps in wide 
lower wad ies. (3) Widespread south of AI-Ain towards AI Liwa on gravels, 
\\uere is it locally dominant. 
Medicinal uses: The whole plant includ ing the seeds is used for medicinal 
purposes. It is used to improve bad breathing chest pain, conjunctivitis, 
constipation, d iabetes, lowering fevers, skin rash, abdominal pains colic, to 
remove stomach worms, i ncrease lactation and antihelrninthic (Aynehdhi et aI . ,  
1 982; Ghazanfar, 1 994) .  
Chemical composition : The leaves, roots and seeds contain 4-indole alkaloids 
such as polyneuridine, sewarine and tetrahydrosescamine (Mukhopadhay et aI . ,  
1 98 1 ;  Ghazanfar, 1 994). 
Flowering and fruiting: February to April (Ghazanfar, 1 994). 
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Figure 4: Rhaza stricta 
(A) Whole plant (EI-Ghonemy, 1 993). 
(B) Fresh branches. 
3 3  
4. Teu criu m mascatense: 
Scientific name: Teucnum rna catense. 
Family name: Labiatae. 
Local name: Jaada, Jaadah (EI-Ghonem " 1 993). 
Descri ption: Perenial shrub, 1 0-25cm tal l, stems ha e a woody base, erect or 
ascending (Fig. 5 ). Flowers sessile congested in terminal heads and purple to 
pale-violet in colour (Wester, 1 989). 
Distribution: Fairly widespread in smal l groups at upper elevations; also plants 
are found in desert plantations at Shwayb (Wester, 1 989). 
Medicinal uses: The leaves and flowers-heads are used for the treatment of  
colic diabetes stomach pain, fever, renal disinfectant and malaria fever. The 
whole plant is used as an analgesic, antibiotic, purgative and antipyretic agent 
(Arnold et aI.,  1 99 1 ; Saleh et aI.,  1 993) .  In Egypt, the plant is used as a 
hypoglycaernic agent, appetizer, and expectorant (Mahmoud, 1 980). 
Chemical composition : The plant contains diterpenoids i ridoid glycosides, 
volati l e  oi ls and various flavonoids (Rizk, 1 986). 
Flowering and fruiting: March to May (Ghazanfar, 1 994). 
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Figure 5: Teucrium mascatense 
(A) Whole plant (EI-Ghonemy, 1 993). 
(B) Dried branches. 
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5.  Moringa peregrina: 
cientific  name:_Monnga peregnna. 
Fami ly name: Moringaceae. 
Local name: shoo, ban, ysar (El-Ghonemy, 1 993 ) 
Descdption: Tree up to 1 2m tall but often shorter, with branches and wi l lo\\') 
appearance. Leaves are few, tiny, and oblong on outer branches that droop in 
need le- l ike fronds (Fig. 6). Flowers tend to appear before leaves, with white 
petals with purple near centre (Wester, 1 989). 
Distribution: This tree is very common at low to intermediate elevations 
especial ly in Russ AI Jibal where it is a dominant tree on steep slopes. Also, the 
plant is scattered throughout Fujeirah at higher altitudes, and upper flanks of 
Jabal Hafit (Wester, 1 989; El-Ghonemy, 1 993). 
Medicinal uses: I t  is  used in  the UAE as a very popular herbal medicine for 
several d iseases such as infection of the respiratory tract, cardiac stimulant in 
asthma, diabetes, counter irritant, neuropathy, headache, earache. intermittent 
fever epilepsy, hysteria, paralysis, dropsy, hepatomegaly and splenomegaly and 
tetanus (EI-Ghonemy 1 993) .  
Chemical composition: Except for linolenic acid the seed oil  contains all  the 
fatty acids that are found in o l ive oil (Ghazanfar, 1 994). 
Flowering and fruiting: April to May (Ghazanfar, 1 994). 
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Figure 6: Moringa peregrina 
(A) Whole plant (EI-Ghonemy, 1 993). 
(B) Dried branches. 
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6. Ziziphus spina-ch risti: 
Scientific name: ZlZIphu spma-christl. 
Family name: Rhamnaceae. 
Local name: eder, Sider ( EI-Ghonem , 1 993). 
De criptioo:  Tree up to 1 2m tall ,  with spiny or unarmed branches ( Fig. 7) 
Leaves are o\ ate with obscurely crenate margins. Fruit is globose drupe, fleshly, 
orange- eUm when ripe (Ghazanfar, 1 994). F lowers are smal l ,  green, in axi l lary 
cymes ( Rizk and EI-Ghazaly, 1 995). 
Dish; bu tion : The tree is common in mountains. It is also common in lower 
wadis and rocky foothi l ls .  The tree can also be found along the coasts (Wester, 
1 989). 
Medicinal uses: The plant is used for l iver d iseases, eyewash, antiseptic, 
d emulcent, astringent, depurative, emoll ient, laxative, pectoral, refrigerant, 
yenereal diseases ( Duke, 1 987) .  The plant is also used for the treatment of 
blisters, bruises, chest pains, dandruff, fractures, headache, mouth and gum 
problems (Ghazanfar, 1 994). Extract of p lants l eaves have hypoglycaemic effect 
( Anand et al. ,  1 989). 
Chemical composition :  The plant contains alkaloids, betulic acid, ceanothic 
acid. It also contains tannins, flavonoids, rutin, hyperin, quercitrin and glucoside 
(Rizk and Al-Nowaihi, 1 989). The bark of the plant contains ziziphine-F, 
j ubanine-A, and sapinanine (Abdel-Galil  and EI-Jissry, 1 99 1 ). 
Flowering and fruiting: September to November (Ghazanfar, 1 994). 
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Figur'e 7 :  Zizlphus spina-christi 
(A) Whole plant and fruit (EI-Ghonemy, 1 993). 
(B) Fresh branches. 
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7.  Citrullus colocynth is: 
cienti fi c  name: Crtrullus co 10 cyn this. 
Family name: Cucurbitaceae. 
Local name: Handal (El-Ghonemy, 1 993). 
Descri ption:  Perennial herb \vith postrate, creeping stems with tendrils; whole 
plant is scrabid.  Lea es alternate, 3-5 lobed, ovate to cordate in  outline. Flowers 
are solitary and yellow (Fig. 8) .  Fruit is globlse gourd, 5 -9cm in diameter, yellow 
or ariously green and yellow striped, smooth. Seeds are embedded in white flesh 
b itter (El-Ghonemy, 1 993). 
Distribution:  Common in central desert and in alluvial plains after rain; also 
along the East Coasts. Occasional in towns (Wester, 1 989). Citrull us colocynthis 
is a member of the family Cucurbitaciae. TIlls plant grows widely in the Arabian 
and Sahara deserts and in Sudan and introduced by Arabs in the middle age to 
S pain and Cyprus (Abdel-Hassan et al . ,  2000). 
Medici n al uses: Seeds of this plant are used for the treatment of diabetes. The 
leaves of this plant are used for the treatment of jaundice and asthma The root is 
used in inflammation of  the breast, amenorrhoea, jaundice, joint pains, and used 
exiemally in ophthalmia and in uterine pains (Kirtikar and Basu, 1 984; Baquar 
and Tasnif, 1 984). 
The fruit is used as a cooling purgative antibelminthic, antipyretic, pungent, 
and canninative. Also, it cures ascites, tumours, u lcers, leucoderma, asthma, 
bronchitis, jaundice, urinary discharges, tuberculous glands of the neck, 
enlargement of the spleen, dyspepsia, constipation, anaemias, throat diseases, 
elephantiasis and is useful in abnormal presentations of the foetus and in atrophy 
of foetus. It is also used in the treatment of amenorrhea (EI-Ghonemy, 1 993; 
Kakarani and Saluja, 1 993) .  
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In addJuon, tills plant has hypoglycaemic effect (Bel lakhdar et al . ,  1 99 1 ;  
Zlyyat et al . ,  1 997) The plant is used to treat dog, and snake bites, diabetes colic 
lung problems, anerrua, stomach pains, intestine problems, \vorms, and for head 
and tooth pains (Ghazanfar, 1 994). 
Chemical composition :  Components of the dried pulp of fruit i nc lude 
cucurbitancin B and E and B I and L in the sterns. The glycoside, col 0 cyntlus, 
consists of elatrin It also contains sterols, al kanes, aliphatic al cohol and 
alkaloids. The peel contai ns a volat i le oi l  consisting of hexanoic acid heptanoic 
acid, l imonene anethol, benzyl alcohol, octanoic acid, citral, geranyl acetate, 
ani saldehyde, decanoic acid, methyl heptanone, phenyl ethyl alcohol, methyl 
eugenol and citmel lol  (EI-Ghonemy, 1 993; Ghazanfar, 1 994· Rizk and EI­
Ghazaly; Rizk, 1 987). 
Flowering and fruiting: February to April (Ghazanfar, 1 994) .  
C colocynlhis i s  a member of  the family Cucurbitaciae. C colocynth IS is 
commonly known as the bitter cucumber or bitter apple. The fruit and dried pulp 
of C colocynthi was used as a traditional medicine mostly for constipation 
( Arena and Drew, 1 980). The seed tar was used in East Africa by nomads in 
traditional medications appl ied to skin (Habs et ai, 1 984). Many investigators 
used the fruits o f  the C. colocynthis as antitumour drug (Faust et ai, 1 989). 
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Figure 8: Citrullus co!ocynthis: 
(A) Fruit and flower of Citrullus 
colocynth is (Rizk EI-Ghazaly, 1 995). 
(B) Dried fruit and seed of Citrullus 
colocynthis. 
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Obj ectives of th is  Study 
The main objecti e of  tllis study I S  to screen some local UAE medicinal 
plants for their effects of insul in secretion in vitro In addition. to select the most 
effective plant to further study its effect on gl ucose homeostasis in vivo.  
Depending on the results of the in vitro e periment, the most effecti e plant (c. 
colocynthi ) \\�th the most consistent effect in evoking insul in release was chosen 
to complete the in vivo experiment. 
S p ecific a i m s  of t h is s t u d y :  
1 .  To elucidate the hypogJycaemic effect of  aqueous extract of C. co!ocynthis 
seeds in  normal and STZ-induced diabetic rats. 
2. To examine the role of  aqueous extract of  C. colocynthis seeds on plasma 
i nsulin levels on normal and diabetic rats. 
3 .  To investigate the effect of  aqueous extract of  C. colocynthis seeds on 
kidne and l iver functions. 
4. To investigate the effect of aqueous extract of  C. cofocynthis seeds on the 





L C H E M IC A L S  USED A N D  TH E I R  SO U R C ES 
Dulbcco ' s  Modified Essential Medium (DMEM ), essential and non-essential 
ammo acid solution, newborn calf serum, penici l l in-streptomycin solution, 
HE PES buffer, Bio-Rad Protein Assa ( Bio-Rad Laboratories, NY, USA) and 
streptozotocm were purchased from Sigma Chemicals (St Louis, MO, USA). 
I nsulin kits were obtained from DRG Instruments GmbH (Germany). Standard 
laboratory chemicals used for processing of tissues and other laboratory 
techniques were acquired [Tom either BDH (Poole, UK) or Sigma (St Louis, MO, 
USA). The immunohistochemical staining was performed by the Labelled 
S treptavidin B iotin method using (DAKO LSAB peroxidase kit) that purchased 
from DAKO Corp. (Carpenteria, CA, USA). 
I I . IN VITRO E X P E R I M EN T  A N D  M E D I C I N A L  P LANT 
S C R EE N IN G  
n . l .  A n im a l  
Male Wlstar rats weighing 1 70-220 g were used i n  this experiment. Rats 
were obtained from the Faculty of Medicine and Health Sciences (FMHS), United 
Arab Emirates University. The animals were raised and maintained in plastic 
cages and fed on a standard laboratory chew and tap water ad libitum. 
n.2. Col lection of the p la n ts a n d  p rep a ra tio n of a q u eo u s  extracts 
Leaves of Rhaza stricta ( Al Harrnal) and Tephro ia apollinea (Dhafra) were 
collected from Al-Hajjar M ountains, Al-Ain d istrict i n  February, 2000, and were 
shade dried. Zygophyllum simplex (Al hirm) leaves were col lected from Haft  
Mountains in March, 2000. Moringa peregrina (Shoo) leaves and Ziziphus spzna­
cristi (Al seder) leaves were col lected from Al-Ain district, i n  January, 200 1 .  AI 
Herm., Al Shoo and Al Seder aerial parts were dried in direct Sull. Cztrullus 
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COiOCY?7fhi (Handal) seeds and Teucrium mascatense (Jaadah) aerial parts were 
bought from local market in March, 200 1 .  
Table 1: Plants used in the study and their dry weight yields per 1 ml of extract 








Citrullus colocynthis Handal Cucurb itaceae 7 .9 
Zygophyllum simp/ex Hirm Zygophyl laceae 1 7 .2 
Tephrosia apollinea Dhafra Leguminosae 1 2.5 
Teucrium mascatense Jaada Labiatae 1 2.4 
Rhazya stricta Harmal Apocynaceae 1 9.4 
Ziziphus spina-cristi Seder Savadoraceae 23 .6 
Moringa peregrina Shoo Moringaceae 1 2.8  
Herbs were botanically  authenticated and voucher specimen of  each plant 
was deposited at the herbarium of the UAE University. A l l  the dried plants were 
powdered in a grinder. Powdered plants (5 g each) were macerated in 1 00 ml of 
disti l led water with continuous stirring at room temperature for 1 6  hours. 
Thereafter, the suspension was fi ltered using steri le gauze and filter paper 
(Wattrnan No. 2). The fi l trates of most plants were further steri l ized usmg 
mil lipore fi lter (0.22 �m) in order to make it suitable for tissue culture 
experiments (Subramoniam et al. ,  1 996). 
n.3. Tissue c u ltu re 
Pancreatic tissue explants were prepared as described by Rouff and Hay, 
1 979 and Hay, ( 1 979), and as modified in  our laboratory. B riefly, animals were 
decapitated by cervical dislocation. Rat abdominal skin was steril ized with 70% 
alcohol; skin dissected, and the pancreas L ifted with a pair  of forceps. Pancreas 
adhesion to the sp leen was removed with a pair of fine scissors. The gland was 
placed in a sterile petri dish containing media and transported to a horizontal 
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lammar flow hood nder completel sterile condition, the pancreas was washed 
\\1th steri le  medIa and placed in a new petri dish. Further russechon was 
performed to remo\ e assocIated fat and connective tissue. Pancreas was chopped 
into smal l (2 mm3) pIeces for tissue explants. Tissue was plated into 24-wel l 
cuJ ture plates containing 1 ml plating media (AppendIx I). Tissue explants were 
incubated in C02-incubator at 37°C and 95% humidity for 48 hours. Thereafter 
medIa and tissues fragments were col lected separatei and kept frozen unti l 
assayed for insulm and protein analysis.  
I T .4. St im u la tion of pa n c reatic tissu e with p l a n t  ex t ra cts 
Tissue explants , ere incubated with and without different concentrat IOns 
(0.2, 1 ,  2, 4, 1 0!ll) of the plant aqueous extracts. Each experimental group was 
represented by 8 indi idual wel l s  (4 per plate). Media and plant aq ueous extracts 
were added to the culture plates and were placed in the incubator for 
reconditioning before the tissue explants were plated. Pancreatic tissue explants 
(2 mm3) were then placed in the (one piece per wel l )  wel l .  Since tissue explants 
,,,,ere relatively di fferent in size and total protein concentration in each well 
corresponds to the relative size of each piece, the total concentration of protein in 
each well was determined and insulin concentration in the supernatant was 
expressed per rng protein of pancreas. 
IT.S. I n s u l i n  E LISA 
Insulin was determined using a DRG immunoenzymetric assay kit 
(Marburg, Germany) for the quantitative measurement of insulin in serum and 
plasma The insuJ in EIA is a solid phase enzyme amplified sensitivity 
immunoassay performed on microtiter plate. A microtiteration plates with 96 anti­
insulin coated wells were used. A standard curve was constructed using 
appropriate standard points (3 . 5 ,  1 5, 45, 133 ,  435 IllU/rnl).  The procedure was 
conducted as described in the kit manual. Briefly, 50 II I  of standard, control, or 
sample were dispensed into the appropriate wells followed by addition of 50 III of 
anti-insulin-HRP conjugate to each welL Thereafter, the plate was incubated for 
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30 min at room temperature usmg honzontal shaker set at 700 ± 1 00 RPM After 
the mcubatlon period, the l iquid reagents w'ere aspirated from each wel l .  At the 
end or the incubation penod, washi ng solution \ as dispensed into each well 
(O.4mll wel l )  and was remo ed b aspiratIOn. Washing step was repeated twice. 
ubsequently 200 j..l l or the fTeshly prepared revelation solution 
( tetrameth Ibenzdine, TMB-H202) was dispensed into each wel l and incubated 
for 1 5  min on a horizontal shaker (700 ± 1 00 RPM) at room temperature. At the 
end of incubatlOn period, 50 III of stopping reagent ( H2S04) was added to each 
wel l .  Finall.-, the absorbances were read and the results were calculated (Fl ier et 
al . 1 979; Frier et al . ,  1 98 1 ;  Judzewitsch et al . ,  1 982; Kosaka et al. ,  1 977 ;  Starr et 
al . ,  1 978) 
1 1 .6. P rotein a ssay 
Protein assay " as determined using Bio-Rad determination kit (Bio-Rad. 
USA). The assa was based on the reaction of protein with an alkaline copper 
tartarte solution and Folin reagent. The diluted dye reagent was prepared by 
diluting 1 part dye reagent concentrate with 4 parts distil led water. Then, the 
diluted dye reagent was filtered through Whatrnan # 1 fi lter to remove particulates. 
A protein standard curve was constructed using ten di lutions of the provided 
protein standard. Exactly 1 00 !ll of each standard and unknown sample solution 
was pipetted into a clean, dry test tube. Diluted dye reagent ( 5 .0 ml) was added to 
each tube and voTte '. Then, tubes were i ncubated at room temperature for 30 min, 
absorbance was measured at 595nm and protein concentrations were calculated, 
( Bradford, 1 976; Reisner et al.,  1 975 '  Sedmack and Grossberg, 1 977 ;  Compton 
and Jones, 1 985;  Spector, 1 978;  Duhamel et al . ,  1 98 1 ;  Macart and Gerbaut, 1 982). 
ID. IN VIVO EXPE R IM E N T  
m. l .  P repa ration o f  aq u eo u s  ex t ract of C. co locynthis 
Cztrullus colocyn this seeds were shade dried and powdered in a grinder. A 
suspension of 200 g of the powdered plant in 400 rnl of d istil l ed water was 
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macerated ill dlstu led \V ater [or 1 h at room temperature with continuous shaking. 
The ffilxture \ as filtered usmg steri le  gauze fol lowed by glasswool filtration. A 
fresh fi ltrate was used [or the In VIVO experiments (Subramoniarn, 1 996). 
l l I .2 .  A n im a ls 
Male Wistar rats ( 1 70-250g) used ill this stud were raised and housed in the 
animal facihty o[ the Faculty of Medicine and Health Sciences (FMHS), United 
Arab Effilrates Uni versit , Animals were maintained at 22 ± 2°C and 1 2-h l ight 
!dark c. c1e. The animals were maintained on standard laboratory animal chew 
with food and tap water ad libitum. 
l l l .3. I n d u ction of d iabetes m el l itus 
Streptozotocin (STZ) is a derivative of the mould Streptomyces grieus. This 
material can induce severe insul in-deficient diabetes in rats and other rodents, 
either by giving a single large dose (50- 1 00 mglkg in rats) or multiple smal ler 
doses, which can induce autoimmune diabetes rather than i sl et toxicity. The most 
widely used method for inducing diabetes (IDDM) in animal models is a s ingle 
intravenous or intraperitoneal inj ection of STZ. With a dose of 50-60 mglkg of 
STZ, insul in wil l  fal l  to 1 0-30% of the normal leading to hyperglycaernia (20-30 
mmolll) , polydipsia, polyuria, and body weight loss. STZ causes B-cel l  necrosis 
and d iabetes supervenes within 24 h, by damaging B-cell  membrane and inducing 
DNA strand breaks (Pid.'Up and Wil l iams, 1 997).  
In this experiment diabetes was induced by a s ingle intraperitoneal injection 
of a buffered solution of STZ (0.5 M sodi um citrate, pH 4.5)  at a dosage of 60 
mglkg of body weight (Adeghate, 1 999a). The animal s  were considered diabetic if 
fasting blood glucose level values were more than 1 26 mg/d! .  
l l l .4. In Vivo Exp erimental  Design 
Eighty rats were randomly assigned into eight experimental groups. The first 
group served as normal non-diabetic control group that consisted of normal rats 
49 
wlth food and water onl (normal non-dJabellc group). The second group \ .... as 
pOSIt I  e control (dIabetic group), \cvruch was inj ected with streptozotocin \\lth 
food and \ ater. The third, fourth and fi fth (dlabetlc treated) groups were injected 
with streptozotocin and feed with three different doses of the water extract of the 
C' colocynthi ; 10\ dose ( 1  ml/kg), moderate dose (2 ml/kg) and high dose 
(4ml/kg). The sixth, se enth and eighth (non-diabetic treated) groups were normal 
rats fed with the same three doses of the plant e mact that were gi ven to the 
diabetic treated groups. 
For diabetic treated groups, the plant e tract was administrated daily by oral 
i ntubation for n 0 weeks after one week from induction of diabetes. However, for 
other normal groups the plant extract was administrated daily from the fi rst day 
by oral i ntubation for nvo weeks. 
At the end of the experimental period, all animals (diabetic and non-diabetic 
groups) were sacrificed , lUlder anaesthesia. a Irud-line abdominal incision ,,,as 
made and the p ancreas was rapidly removed and cut into smal l fragments, and 
fixed overnight in freshly prepared Zamboni's fixative for immunohistochemical 
studies (Zamboni and de Martino, 1 967). 
1 1 1.5.  M easu rem ent  of b lood g l u co se levels a n d  body weigh t  
The fasting blood sugar level was eval uated twice a week for each rat. Blood 
was col lected from the tai l tip between 1 0 :00 h and 1 2 :00 h after and overnight 
fasting (no food) and blood glucose was determined using Sure Step glucometer 
(Life Scan, Johnson and Johnson, USA). The bod weight was determined twice 
a week for each rat. Measurement of body weight was taken between 1 0 :00 h and 
1 2 : 00 h. 
il l.6. B iochem ical  A n a lysis 
Insulin measurement was performed as described p reviously by using a 
DRG irnmunoenzymetric assay kit for the q uantitative measurement of insulin in 
plasma (Germany). 
so 
Blood urea mtrogen ( B  ), creatmme, alkalme phosphatase alanme 
anunotransferase, aspartate armnotransferase, lactic dehydrogenase, gamma­
glutam. I transferase calCium, phosphorus, sodIum and potassIUm were perfonned 
in AI-Qattara Lab on Di mensIOn cl Iru cal cherrustry system (DimensIOn AR 
Deh'¥ are, A) Al l kIts for these tests ( rea mtrogen Flex Thl reagent cartndge, 
Creatinme Fle. f\.1 reagent cartrIdge, Alkalme phosphatase FlexTht reagent 
cartndge, Alarune ammo transferase Flex 1 I reagent cartridge, Aspartate 
amInotransferase Flex Thl reagent cartridge LactiC dehydrogenase FIe TM reagent 
cartridge, Garnma-glutam) I transferase Flex Thl reagent cartndge, CalcIUm Fie .Thl 
reagent cartridge phosphorus FlexThl reagent cartndge, Sodium Flex™ reagent 
cartridge and PotasSium FlexThI reagent cartndge) were purchased from DADE 
B EHRING ( DADE Behnng, USA). 
I T I . 7. H isto logica l a n d  i m m u no h istoc hem ical  tec h n iques 
0 1 .  7. 1 .  a. Processing of tissue samples 
At the end of the experiment, nonnal and treated rats were anaesthetized 
\\;th chloroform A long abdominal incision was made and the pancreas was 
qUlckly remo, ed, trimmed of connective tissue and fi 'ed for 72 h in Zamboni's  
sol ution. After the fixation process, the samples were dehydrated in  ascendmg 
concentratIOn of ethanol, cleared in xylene and embedded in paraffin wax. 
S ections of 6 J..lm thickness were cut and processed for haematoxyl in eosin 
staming and for Immunohistochemistry. 
I T I .7. Lb. Staining witb baematoxylin and eosin stain for paraffin sections 
Sections were dewaxed in xyl ene (twice, 2 min each), then hydrated through 
graded alcohols ( 1 00% twice ( 1  min for each), 95% ( l  min), 70% ( 1  min) to 
water ( l  min). Thereafter, the sections were stamed in alum haematoxyhn of 
chOice for 4 min, fol lowed by few dips m v ater. After that the sectIOns were 
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differentiated in 1 % aCld alcohol .  ext. s l ides \\"ere \\ ashed in run ing tap \\ ater 
(5 nUn) and stained in eosin (30 s). F inal ly sections were dehydrated through 
graded ethanol 70% ( 1 5 s), ethano l 95% ( 1 5  s), ethanol 1 00% (twice, 2 min each) 
then cleared in y lene (twice, 2 nU n each); and mounted in Cytoseal (Stephens 
Scientific Riverdale, USA). 
1 1 1 .7. 2. a. Immunoh istochemistry 
Three rats from each group were used [or this  experiment. The isolated 
pancreas was trimmed free of adherent fat and connective ti ssue and then cut into 
smal l p ieces (2 mm3) and fixed overnight in freshly prepared Zamboni ' s  fixative 
(Zamboni and de Martino, 1 967). The tissues were later dehydrated in graded 
concentrations of ethanol. Tissues were embedded in paraffin wax as describe in 
the previous section. 
Sections of 6 11m thickness were deparaffini sed with xylene (twi ce, 5 min 
each) and then transferred into absolute ethanol (twice, 5 min each). The sections 
were then incubated for 30 min in 0.3% hydrogen peroxide solution in methanol 
to block endogenous peroxidase activity. The sections were hydrated in 
decreasing concentration of ethanol and brought to Tris  buffered sal ine (TBS). 
The sl ides were washed 3 times (5 min each) in TBS. After washing in TBS, the 
tissues were marked around with a Dako pen to prevent solution draining away 
from the t issue sections. The staining procedure was started by incubating the 
sections with blocking reagent. After 30 min the b locking reagent was drained off 
and appropriate d ilution of primary antibodies (anti insul in and anti glucagon) and 
negative control reagents were applied. The sections were incubated in primary 
antibodies for 24 hour at 4° C temperature. The sl ides were then washed (3 times 5 
each) with TBS and incubate for 30 min with pre-d iluted b iotinylated anti-rabb it 
or anti-mouse IgG for 30 min, washed in TBS (3 times, 5 min each) and 
subsequently incubated in streptavidin peroxidase conjugate for 45 min. After a 
fi nal wash in TBS (3 times, 5 min each), the peroxidase activity was revealed by 
incubating the specimens for 3 min i n  3,3- diarninobenzidine tetrahydrochloride 
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contammg 0.03% h drogen peroxide in TB The sl ides were later washed for 1 0  
nun under runnmg tap \ ater, and counterstained \\ith haemato ylin for 30 s They 
were then di iTerentiated in acid ethanol and washed for 1 0  min under runrung tap 
water, dehydrated in ascending grades of ethanol, and subsequently cleared in 
ylene for longer time to dissolve the Dako pen mark. The tissues were 
subsequently mounted in Cytoseal 60 (Stephens Scientific, USA). Slides were 
examined under Zeiss Axiophot microscope and immunoposltive area of the tissue 
sections v ere photographed (Adeghate, 1 999a). 
I I I .7 .  2. b. Morphometric analysis 
Morphometric analysis of insul in  and glucagon i mmunoreactive cel ls .  The 
total number of cel ls in the is lets o f  the pancreas of normal and diabetic rats was 
counted using a VID V Image Analysis System (Synoptics, Cambridge C B4 1 TF, 
UK) attached to a l ight microscope. In addition, insulin and gl ucagon positive 
cells \-" ithin a given islet were also counted. Immunoreactive cells were counted in 
the sections at X 40 magnification. A total of 5 random fields per slide were 
exami ned from a total of 6 slides for each group. The mean of the percentages of 
insul in and glucagon positive cel ls was calculated for each is let .  
Statistical analysis 
Data were analyzed by ANOVA (analysis of variance) and student t test was 
used where appropriate to detect differences among individual means. The criterion for 




I. IN VITRO E X P E R I M E N T  
1 . 1 . Screen i n g  o f  m ed ic i n a l  p lants a q u eo u s  extract  fo r their  effect 
of i n su l i n  sec retion 
Cztrulfu colocynlhis increased insulin secretion by 1 08 ± 5. 1 ,  1 2 1  ± 9. 8, 1 3 7 
± 1 2.6, 1 35 ± 1 6. 1  and 1 34 ± 1 2.4  when pancreat ic t issue fragments were 
mcubated \\' ith 0.2  �l, 1 )..1., 2�, 4 �l and 1 0  f..I. l of the e>..1ract, respectively. 
Furthermore, aqueous e dract of Zygophyllum simplex caused an initial decrease in 
msu lin release " ith 0. 2 f..I.l of the extract and subsequent increases when 1 �, 2 � 
and 4 III of the extract were added to the medium This increase was followed by a 
decrease in insulm secretion when 1 0  f..I.l of the extract was incubated with 
pancreatic t issue fragments. Aqueous extract of Tephrosia apollinea was able to 
increase insul in release only at a concentration of 2 �I (Table 2). Extracts of other 
plants, including Rhaza stricta, Moringa peregrina, Ziziphus spina-cristi and 
Teucrium mascatense fai led to evoke s igni ficant increases in insulin release after 
mcubation with pancreat ic t issue fragments. 
l l .  IN VIVO EXPE R IM EN T  
II . 1 .EfTect of aqueous extract o f  C colocynthis o n  insulin secretion 
Figure 9 shows the effect of aqueous extract of C. colocynthis on insul in 
secretion in non-diabetic groups. 1 rnl of the extract had the most sign ificant (p 
<0 000 1 )  effect on secret ion of insulin. The level of plasma insul in increased from 
2. 8 7  to 3 .22 (f..I.lU/rnl) when 1 ml  of the extract of  the plant was given. Moderate 
doses (0. 5 ml) did not induce any significant release in insulin secret ion. The basal 
level only increased from 2 .72 to 2. 82. The effect of a lower dose (0.25 ml) was 
even less significant and a change in the basal level was only from 2. 6 1  to 2.62. 
These results c learly indicate that the effect of C. colocynthis extract on insul in 




s far as the effect of C colocynthls on diabetic animals 1S concerned al l 
concentratlOns of  the plant extract had a stimulatory effect on msul in secretion In VIVO. Low 
concentranons caused high increases III insul in release from normal rats However. higher 
concentratJons of the plant extract i nd uced an e en higher (p < 0.0005) increases 10 insul i n  
secretion (Fig. 1 0). 
Table 2: Effects of aqueous extracts of different plants used in the In  VitrO study on insulin 
release 
-
Plant extract Dilutions of extract in media 
0.2f.1L 1 f.1L 2 f.1 L  4 f.1L 1 0  f.1L 
Citrullus • • • 
colocynth is 
1 08 ± 5 . 1 1 2 1  ± 9.8 1 37 ± 1 2.6 1 35 ± 1 6. 1  1 34 ± 1 2 . 4  






simplex 88 ± 1 0. 1  1 33 ± 1 6  1 39 ± 1 2.9 1 42 ± 1 7 .3  98  ± 8.2 
Teph rosia 
• 
apollinea 1 1 8 ± 12 . 3  1 07 ± 7 .9 
1 32 ± 1 4. 1  1 1 5 ± 9.9 1 1 9 ± 12 .8  
Teucriu m 
mascatense 79 ± 8. 1 85 ± 5.9 83 ± 7.9 86 ± 1 0.7  84 ± 6.8 
Rh azya 
stricta 80 ± 8.5 78 ± 8. 1 76 ± 1 0.6 64 ± 5.4 57 ± 5.4 
ZiJJphus 
spina-cristi 62 ± 6.7 56 ± 5 .8  57 ± 7 .4  51  ± 5 .8  36 ± 2 .5  
Moringa 
peregrina 70 ± 7 .7 54 ± 4 .7 
57 ± 4 .4  53 ± 6. 1 57 ± 8.2 
Data are shown as mean ± S.E of  insulin release in relation to the blank. Each mean is 
calculated from the percentage increase in  insulin  release compared to the blank (n= 8 wel ls). 
* = Significant increase in  insul in  release compared to the control (blank) at P <0.05. 
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There i a Jgnliicant mcrease m the plasma msulm level m rats treated \\lth 10\\ , 
moderate and rugh doses of  the plant extract compared to that of control rats 
I I .2 .  flect of  aqueou ex tract of  C colocynthis on blood gluco e level 
Plasma gluco e le\ els \\ ere s igni ficantly ele\ ated m TZ-dJabetlc rats Oral 
ad rrunt  tratlOn of aqueous extract of colocynthl seeds given over 2-\\'eeI... 
penod s lgru ficantl) reduced plasma glucose le\ el In non-diabetic and diabet iC 
rats The mean blood glucose levels of fasted normal (non-diabet iCS groups) 
an tmals treated b) \ arlous concentration 0 f the aqueous exiract of colo �ynthLS 
are hO\m m Figure 1 1  Lo\\ dose (0.25rnl) has no effect on fast ing blood glucose 
The basal level changed from 78 .4  to 79.4 (mg/dl)  There was a Significant 
decrease In glucose level fro m 76.2 to 67.3 (mg/d l)  when moderate dose (0 5 rnJ )  
of the plant ex1ract "" as gi ven The high dose has the maximum hypogl caerruc 
effect (p <0 0005). The basal level changed from 79.6 to 62. 7  (mg/dl )  after the 
ad mintstratIon of 1 rnJ of . colocynthls. These results showed that C colo ynthls 
reduced blood glucose m a dose-correlated manner. 
The effect of aqueous extract of C colocynthls on b lood glucose of fasted 
diabetic animals treated by various doses of the ex1ract is shown in FIgure 1 2  
There " as  a mintmum h pogl, caemic effect (from 326 8 to 30 1 . 7 )  when low dose 
(0 25rnJ) of the seeds extract was gi en orally to hyperglycaemic rats. S igni ficant 
h poglycaemic effect (the mean change from 323. 2 to 2 1 0. 3  mg/dI )  was observed 
when diabetic rats were given 0.5 rnl o f  the aqueous ex1ract o f  C. colocynthls. 
H igh doses ( 1  rnI) have the maximum hypoglycaemic effect. The mean blood 
glucose level decreased from 340. 1 to 1 1 8. 2  (mg/dl )  
ll .3. Effect o f  aqueous extract o f  C colocynthis o n  body weight 
As shown m FIgure 1 3, the body weight of non-diabetic treated rats was not 
Significantly different from those of normal control rats. In figure 1 4. the effect of 
aqueous extract of C. colocynthis on bod weight of diabetic groups IS sho\\TI. 
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Figure 9: Effect of aqueous e. tract of Citrullus colocynth is on plasma insulin 
secretion in fasted non-dIabetIc rats (Data are mean ± SO, n=9). 1 ml of the plant 
extract induced slgruficant (* = P <0 000 1 )  quantItIes of InSulm secretlOn 
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Figure 10:  Effect of aqueous extract of Cztrullus colocynthis on plasma InSulm 
secretion m fasted dIabetic rats (Data are mean ± SO, n=9). 0 .25ml, 0 5ml, 1 ml of 
the plant extract mduced yery sIgnificant (* = p <0.000 1 )  quantitIes in secretIon 
release compared to control. 
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Figure 1 1 :  Effect of aqueous extract of Citrullus colocynth is on blood glucose 
level in fasted non-diabetIc rats (Data are mean ± SD, n=9). 1 rnl of the plant 
extract induced very significant (* = p <0.0005) decrease in blood glucose level 
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Figure 1 2 : Effect of aqueous extract of Citrullus colocynthis on blood glucose in 
fasted diabetic rats (Data are mean ± SD, n=9). 0 .5rnl, 1 rnl of the plant extract 
induced significant (* = P <0.00 1 ,  ** = P < 0.00000 1 )  decrease in blood glucose 
level compared to control .  
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Figure 13:  Effect of aqueous extract of Cttrullus co!ocynthis on body weight ill 
fasted non-diabetic rats (Data are mean ± SD, n=9). The plant extract had no 
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Figure 14:  Effect of aqueous exiract of Cttrullus colocynthis on body weight In 
fasted diabetic rats (Data are mean ± SD, n=9). The plant extract had no 
significant effect on body weight compared to control. 
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I I .4. Biochemical effect of C. colocynthi 
n.4.a .Effect of aq ueous extract of C. colocynthis on plasma alanine 
aminotransferase level 
Aqueous e. t ract of . colo ynthlS had no signi ficant effect on alanine 
ammotransferase leyel in non-diabetic rats. On the other hand, aqueous extract of 
. colocynrhls caused s lgn ificant changes on alanine aminotransferase level in 
d labetic rats. There lS no sign ificant effect of  C colocynthis extract of fasted non­
diabetic groups on alanine arninotrasferase in all doses. Moreover, aqueous C. 
colo ynthis extract had a significant effect on alanine aminotrans ferase in fasted 
dwbetic mts ( Fig. 1 6) .  
n .4.b .EfTect of aqueous extract of C. colocynthis on plasma potassium level 
There is no signi ficant effect of aqueous C colocynthis extract on potassium 
level in  non-diabetic normal rats (Fig. 1 7) .  The mean potassium level of fasted 
hypergl_ caernic rats after oral administration of aqueous C. colocynthis ext ract is 
sho\\TI in Figure 1 8  Low, and moderate doses caused no significant change in the 
ie\'el of plasma potassium. However there was a s igni ficant increase in plasma 
potassium level when the rats were fed with 1 mJ of the aqueous extract of C. 
colocynthis. 
l l .4.c.Effect of aqueous ext ract of C colocynth is on plasma sodium level 
The results presented in F igure 1 9  demonstrate that the aqueous C. 
colocynthis e)"'1ract had no effect on p lasma sodium level in non-diabetic normal 
rats. However, in diabetic animals, low dose (0. 2Sml) of the extract caused a 
sign i ficant decrease in p lasma sodium level (Fig. 20). Moderate dose of the plant 
group had no effect on plasma sodium leveL High dose ( 1  rnJ) induced a 
sign ificant increase in plasma sodium level .  
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Figure 1 5 :  Effect of aqueous extract of Cttrullus colocynthis on plasma alamne 
aminotransferase in fasted non-diabetic rats (Data are mean ± SD, n=9). No 
significant effect was induced by the plant extract on alanine aminotransferase 
level compared to control .  
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Figu re 1 6 :  Effect of aqueous extract of Citrullus colocynthis on plasma alanine 
aminotransferase in fasted diabetic rats (Data are mean ± SD, n=9) The plant 
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Figure 17: Effect of aqueous extract of Cttrullus colocynthls on plasma potassium 
le\ el ill fasted non-diabetic rats (Data are mean ± SD, n=9). The plant extract had 



















o O mL 
. 0 .25 mL 
0 0 .5 mL 





Figu re 1 8: Effect of aqueous extract of Cttrullus colocynthis on plasma 
potassium level in fasted diabetic rats (Data are mean ± SD, n=9). 1 ml of the 
plant extract induced significant (* = p <0.04) increase in plasma potassium level 
compared to control .  
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Figure 1 9 :  Effect of aqueous ex.1:ract of Citrullus colocynthis on plasma sodium 
in fasted non-diabetic rats (Data are mean ± SD, n=9) Plant extract had no 
sigruficant effect on plasma sodium level compared to control .  
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Figure 20: Effect of aqueous extract of Citrullus colocynthis on plasma sodium in 
fasted diabetic rats (Data are mean ±SD, n=9). 0 .25ml of the plant extract induced 
sigruficant (* = p <0. 005) decrease, while 1 rnl of the plant ex.1ract induced 
sigruficant (** = p <0.000 1 )  increases in plasma sodium level compared to 
control .  
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I I .4.d . Effect of aq ueou extract of C c% CYlltltis on plasma alkaline 
pho p hatase level 
A low concentration (0. 25m!) of the aqueous extract of C co 10 cyn rhl did 
not cause an signi ficant change in the plasma level of alkaline phosphatase 'Ii hen 
gi, en to nonnal rats (F Ig. 2 1 ). However, moderate and high doses (0. 5, 1 rnl) 
caused a s igni ficant (p <0.000 1 )  increase in alkal ine phosphatase levels from 
(96. 78, 1 02. 1 1  up to 1 1 2 . 33, 1 20.56 UIL), respectivel . 
P lasma alkaline-phosphatase levels were signi ficantly elevated in al l STZ­
diabetic rats from 1 04 up to 257 U/L (Fig. 22). After treatment with plant extract, 
alkal ine phosphatase level remained high in all groups. This indicate that, all 
doses of the aqueous extract of C colocynthls did not have significant beneficial 
effect on plasma alkal ine-phosphatase level 
I I .4 .c. Effec t  of aq ueous extract of C cO/Qcyltthis on plasma gamma-glutamyl 
t ransferase level 
The aqueous ex'tract of C cO!OcynthlS fai led to induce s ignificant increases 
ill plasma gamma-glutamyl transferase level when given orally to normal rats 
(Fig. 23 ). However, there was an increase in plasma gamma-glutamy l transferase 
level after the onset of d iabetes (3 .4 to 7. 7 UIL). After treatment with low and 
moderate doses of the p lant e:x.1ract, a signi ficant increase in the plasma level of 
gamma-glutamyl transferase level (7 .9 to 1 1 . 9, 7. 8 1 1 . 8  UIL) was observed. H igh 
doses of the plant e tract caused a higher but not significant increase in gamma­
glutamyl transferase level (7 .9 to 8. 4UIL) (Fig. 24). 
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1 l .4.f. Effect of aqueous extract of C colocynthis 00 pia rna lactic 
dehyd rogenase level 
The plasma level of lactic deh drogenase in non-diabetIc rats treated with 
low moderate, high doses of the plant extract decreased s ignificantly (0. 25m! :  
2 9 8  to 239.7, 0.5 mI : 28 1 . 9 to 238.4 I ml :  253. 1 to  235  U/L), respect ively. In  
diabetic rats, plasma lactic deh drogenase level increased from 250 to 400 UIL for 
all groups ( Fig. 26). The plasma level of lactic dehydrogenase was st i l l  hIgh after 
oral adnUnistration lov and moderate doses of the plant extract of C. colocyn th is. 
However, high ( 1  m!) of  the plant extract did not cause any significant changes in 
the plasma level of  lactic dehydrogenase when compared to control (334.2 to 
365 6 UIL) 
l l .4.g. E ffect of aq ueous ex tract of C colocynthis 00 blood urea nitrogen level 
Effect of aqueous C. C010cynlhis extract on blood urea nitrogen level in 
fasted non-diabetic rats is shown in Figure 27. Treatment of normal rats with 
different concentration of the plant extract had no significant effect on blood urea 
nitrogen level compared to control .  B lood urea nitrogen level was elevated in al l 
diabetic groups ( Fig. 28).  The level of  blood urea nitrogen in diabetic rats did not 
change significantly after the administration of  different doses of the aqueous 
extract ofC colocynthis. 
II.4.h .  Effect of aqueous extract of C coloCYlLthis on calcium level 
Figure 29 shows the effect of aqueous C. colocynthlS ex1ract on calcium 
level in non-diabetic rats. Oral administration of moderate (0. 5ml) and high ( l ml) 
doses of the plant extract has no effect on plasma calcium level in normal rats. 
Low dose (0.25ml) of the plant extract induced significant (* = p <0.003) increase 
in calcium level compared to control. All doses of plant ex1ract caused no 
significant change in plasma calcium concentration in diabetic rats (Fig. 30). 
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l l .4 . i .  Effect of aq ueous ex tract of C colocynthis on plasma creatinine level 
reatinme level , as measured to deterrrune if there was damage to the 
kidney. Aqueous extracts of the plant fai led to cause significant changes in the 
creatinine levels of normal (Fig. 3 1 )  and diabetic (Fig. 32) rats. There was no 
signi ficant effect on creatinine  level in all non-diabet ic groups Also, for diabetic 
groups there \ as no sigru ficant effect on creatinine level 
l l .4.j . Effect of aqueous extr"act of C colocynth is on plasma phosphorus level 
Figure 3 3  shows the effect of aqueous C colocynthis extract on phosphorus 
level of non-diabetics rats. There \ as no signi ficant change in plasma phosphorus 
le,'el after normal rats were treated with di lTerent doses of the plant ex1ract There 
was no s ignificant change in phosphorus level after treatment of diabetic rats with 
different concentrations of the plant extract (Fig. 34). 
l l .4.k.  Effect of aq ueous extract of C coloCYllthis on plasma aspal'tate 
aminotransferase level 
The effect of aqueous C. colocynthis extract on aspartate aminotransferase 
level in non-diabet ics rats is shown in Figure 35 .  Oral administration of low and 
moderate doses of the plant extract fai led to cause s ignificant changes in the 
plasma aspartate aminotransferase level in normal rats compared to control .  
Figure 36 shows the effect of  aqueous C. colocynthis extract on  aspartate 
aminotransferase level i n  diabetic rats. The plasma aspartate aminotransferase 
level increased more than two-fold after the onset of diabetes ( 100 to 220 UIL). 
Lo\v and moderate doses of the p lant extract fai l ed to bring the p lasma aspartate 
aminotransferase level down to the pre-treatment levels. Low and moderate doses 
(0. 25ml, and 0.5  rnI) of the p lant extract caused a s igni ficant increase in aspartate 
aminotransferase Ie el compared to untreated control .  However, high dose ( l  ml) 
of the plant extract induced a decrease in aspartate aminotransferase level when 
compared to untreated rats. 
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Figure 2 1 :  Effect of aqueous extract of Cztrullus colocynthis on plasma alkaline 
phosphatase in fasted non-diabetic rats (Data are means ± SD, n=9). No 
slgmficant effect was induced b plant extract on plasma alkal ine phosphatase 
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Figure 22:  Effect of aqueous extract of Citrullus colocynthis on plasma alkaline 
phosphatase in fasted diabetic rats (Data are mean ± SD, n=9) .  Plant extract had 
no significant effect on plasma sodium level compared to control .  
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Figure 23: Effect of aqueous extract of Citrullus colocynthis on gamma-g1utarnyl 
transferase in fasted non-diabetic rats (Data are mean ± SO, n=9). The plant 
ex1ract had no significant effect on garnma-glutarnyl transferase level compared to 
control. 
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Figure 24:  Effect of aqueous extract of Citrulfus colocynthis on gamma-glutamyl 
transferase in fasted non-diabetic rats (Data are mean ± SO, n=9). 0.25m1, 0 .5m1 
of the plant extract induced significant increase (*= p <0.000 1 )  increase in plasma 
garnma-g1utarnyl transferase compared to control .  
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Figu re 25: Effect of aqueous extract of Otrullus cofocynthlS on lactic 
dehydrogenase in fasted non-diabetic rats (Data are mean ± SD n=9). The plant 
ex1ract had no significant effect on plasma lactic dehydrogenase level compared to 
control .  
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Figu re 26: Effect of aqueous extract of Citrullus co!ocynthis on lactic 
dehydrogenase in fasted diabetic rats (Data are mean ± SD, n=9). 1 rnl of the plant 
extract induced significant (* = P <0.0003) decrease in plasma lactic 
dehydrogenase level compared to control .  
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Figu re 2 7 :  Effect of aqueous extract of  Cltrullus colocynthis on blood urea 
nitrogen in fasted non-diabetic rats (Data are mean ± SD, n=9). The plant extract 
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Figu re 28: Effect of aqueous extract of Citrulfus co!ocynthis on blood urea 
rutrogen in fasted diabetic rats (Data are mean ± SD, n=9). The plant extract 
caused no changes in the level of blood urea nitrogen compared to control. 
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Figure 29: Effect of aqueous extract of Citrullus cofocynthis on plasma calcium 
le, el in fasted non-diabetic rats (Data are mean ± SD, n=9). The plant extract 
caused no changes in the level of plasma calcium compared to control . 
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Figure 30: Effect of aqueous extract of Citruflus colocynthis on calcium level in 
fasted diabetic rats (Data are mean ± SD, n=9). The plant extract did not cause 
significant changes in the plasma calcium level compared to control .  
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FigUl'e 3 1 :  Effect of aqueous ex1Tact of Citrullus colocynthis on plasma creatinine 
leyel in fasted non-diabetic rats (Data are mean ± SD, n=9). The aqueous extract 
of the plant dId not cause any significant changes in plasma creatinine level 
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Figure 32: Effect of aqueous extract of Citrullus colocynthis on plasma creatinine 
level in fasted diabetic rats (Data are mean ± SD, n=9). Plasma creatinine level did 
not change significantly after oral administration of the plant extract compared to 
control .  
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Figure 33 : Effect of aqueous ex1ract of  Citrullus colocynthis on plasma 
phosphorus level in fasted non-diabetic rats (Data are mean ± SD n=9). The plant 
extract did not induce significant differences in plasma phosphorus level 
























Figure 34 : Effect of aqueous extract of Citrullus colocynlhis on plasma 
phosphorus in fasted diabetic rats (Data are mean ± SD, n=9). The plant extract 
did not induce significant differences in plasma phosphorus level compared to 
control .  
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Figure 35: Effect of aqueous extract of CUrullus colocynthis on plasma aspartate 
anunotransferase in fasted non-diabetic rats (Data are mean ± SD, n=9). The plant 
extracts cause a smal l ,  but not significant changes in the plasma aspartate 
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Figure 36: Effect of aqueous extract of Cztrullus colocynthis on plasma aspartate 
aminotransferase in fasted diabetic rats (Data are mean ± SO, n=9). 1 rnl of the 
plant extract induced significant (* = p <0.000 1 )  decrease in plasma aspartate 
aminotransferase level compared to control .  
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I I I . H isto logy resu lts 
In order to deterrrune the effect of the plant extract on the morphology of 
pancreatic Islet cel l s, \\·e stamed the islets of nonnal and treated rats. The plant 
extract d id not cause an siglllficant morphological changes to pancreatic I slets 
(Fig. 37). The S Ize and the pattern of distribution of Islet of treated rats did not 
appear to be d Ifferent from that of normal rats 
The SIze and the number of pancreatIc is lets appear to ha'v e increased 
(qual I tat Ive assessment) after treatment \\lth different doses of Cltrullus 
colo J:nthl (Fig. 38). Howe er, there were no signifi cant di fferences In the 
morphological appearances of the acinar cel ls and pancreatic tubules, 
Figure 39 sho\\ s l ight micrographs of the pattern of distribution of insuhn in 
the pancreas of nonnal rats. I nsulin  immunoreacti ve cel l s  were numerous and 
found in both the central and peripheral parts of the islet of Langerhans. 
Morphometric analysis  of pancreatic is let cel ls suggests that there is i ncrease in 
the number of inSUl in-positive cel ls .  The increase in the number of insulin 
lmmunoreactn'e cells was dose-correlated. The administrat ion of a low dose 
(0.25mJ)  of the plant dJd not cause any significant increase in the number of 
msulin-positive cells.  However, when moderate and high doses (O.SmJ, I mJ )  were 
gi ven to norma! rats for t\'.o weeks, there " as a marked (p < 0.02) increase in the 
number of insulin i mmunopositive cells (Fig. 39). 
Light micrographs showi ng the pattern of  d istribution of insul in 
Immunoreactive of insul in cel ls in  diabetic rats is depicted in figure 40. After the 
onset of diabetes. insul in i mmunoreacti ,'e cel ls appeared to be fewer (quantitative 
assessment) in  diabetic pancreas without treatment. But in the treated rats insul in 
Immunoreactive cel ls  increase correlate on the dose of plant. 
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In normal rats, glucagon (GLU) t mmunoreact h e  cel l s  were obsened mamh' 
in the peri pher: of the Islet of Langerhans where they form a mantle around the cel ls 
of the mner core of  the Islet (Fig 43) .  In experi mental diabetes, GLU-posltl \ e  cel ls 
\\ ere located m both the central and penpheral parts of the is let of  Langerhans (Fig. 
44) In addition, the number of glucagon-immunoreacttye cel l s  appeared to ha" e 
Increased sigruficant ly after the onset o f  diabetes. 
The oral ad ministratlOn of a Im.\ dose (0.25 rnJ )  of the aqueous extract of the 
plant ex1ract appear to have caused a signi ficant mcrease In the number of glucagon­
posItive cel ls in the islet of Langerhans of  normal rats (Fig. 46) .  In contrast, higher 
doses (0.5 mI, 1 mJ) of the plant extract did not cause any significant changes in the 
percentage distribution of glucagon-immunoreacti \ e  cel ls in the islets of normal rats 
(Fig. 46) 
Morphometric analysis suggests that higher doses of the aqueous extract of 
Crtrullus oloc)'nthls induced large and signi ficant (p < 0.03) increases in the 
percentage distribution of glucagon-immunopositi ve cel ls in the pancreatic islets of 
diabettc compared to control rats ( Fig. 4 7). 
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Fi gure 3 7 .  Light micrographs of pancreatic is lets ( I )  of normal rats.  (Hematoxy l i n  and eosin 
stain) .  
A. Normal control .  
B .  Normal rats treated with C. colocynthis ( l mllkg of aqueous extract).  
C .  Normal rats treated with C. co 10 cyn th is (2mllkg of aqueous extract). 
D .  Normal rats treated with C. colocynthis (4mllkg o f  aqueous extract). 
Note that pancreat ic i slets of Langerhans are located between acinar tissues (thick arrow). There 
i s  no morphological d i fference between the pancreas of normal rats and those treated with 
d i fferent doses of the plant extract. N = peripheral nerve, thi n  arrow = pancreatic duct. 
M agnificat ion : X 400. 
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Fi gure 3 8 .  Li ght micrographs of the pancreas of d iabetic rats, showing pancreatic is lets (I), d uct 
(thin arrow), blood vesse l (bv). H aelnatoxy l i n  and Eosin stain .  
A. Di abetic control .  
B .  D i abetic rats treated with C. co 10 cynth is ( l ml/kg of aqueous extract).  
C .  D i abetic rats treated with C. colocynthis (2ml/kg of aqueous extract).  
D .  Diabetic rats treated with C. colocynthis (4ml/kg o f  aqueous extract).  
The i slet of Langerhans in the diabet ic  group appeared to be smal ler than that of normal rat. 
However, the pancreat ic  i s lets of d iabetic rat treated with d i fferent doses of the plant extract 
appeared to be bigger compared to contro l .  M agni fi cati on X400 
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Fi gure 39.  M icrographs of i nsul i n-immunoreact i ve ce l l s  (arrow) in  pancreatic is lets of non-di abet ic 
rats.  
A. Normal control .  
B .  Normal rats treated with C. co 10 cynth is ( l ml/kg of aqueous extract). 
c .  Normal rats treated with C. colocynthis (2 1n l/kg of aqueous extract). 
D. Normal rats treated with C. colocynthis (41nl/kg of aq ueous extract) .  
Note that there i s  no apparent d i fference in the number and pattern of distri bution of insul in positive 
ce l l s  i n  the treated groups compared to control . bv = blood vesse l . Magnification X400 
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F igure 40.  Micrographs of insul in-i mmun oreactive ce l ls  (arrow) in  pancreatic islets of diabetic rats . 
A. Diabetic control  
B. Diabetic rats treated with C. colocynthis ( 1  m l/kg of aq ueous extract).  
C .  Diabetic rats treated with C. co 10 cynth is (2ml/kg of aq ueous extract). 
D .  Diabetic rats treated with  C. co 10 cynth is (4ml/kg of  aq ueous extract).  
Note that there is  apparent increase in  the number of i nsul in  positive cel l s  with increase in  the dosage of the 
plant extract .  M agn i fication X400 
85 








'0 20 1 
� 0 
0 I 
Pe rce ntage d istri bution of i n s u l i n  
immu nore active ce l l s  i n  the islets o f  n o r ma l  rats 
* **  
T T T T 
Control Dose-1 Dose-2 Dose-3 
G ro u p s  
Figure 4 1 :  Effect of  aqueous extract of  Cztrullu colocynthis on percentage 
distribution of insul in immunoreactive cel1s in pancreatic islet cells in fasted 
normal non-diabetic rats ( Data are mean ± SD, n= 1 8 -30). ( Low dose=0.25rnl .  
moderate dose=0.5rnl, high dose= l rnI) 0.5rnl, 1 rn1 of the p lant extract induced 
significant ( * = p <0.02, ** = p <0. 002) increase in the percentage of insulin 
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Figure 42 : Effect of aqueous Citrullus colocynthis extract on percentage of 
insulin immunoreactive cel ls of fasted diabetic groups (Data are mean ± SD, n= 
1 2-23) .  (Low dose=0. 2Sml ,  moderate dose=0.5ml, high dose= l ml) 0 .25rnl, 
O .Sml, l rnl  of the plant extract induced significant ( * = p <0.00005 , * *  = P 
<0.00000) increase in percentage of insulin i mmunoreactive cells compared to 
control. 
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Figure 43 . M icrographs of gl ucagon-i mmunoreactive cel ls  (arrow) in  pancreati c  i s lets of non­
d iabetic rats . 
A .  Normal control .  
B .  Normal rats treated w ith C. colocynthis ( 1  m l/kg of aqueous extract). 
C .  Normal rats treated with C. colocynthis (2mllkg of aqueous extract). 
D.  N ormal rats treated with C. colocynthis (4mllkg of aqueous extract). 
Note that the pattern of d istri bution of glucagon-pos it ive cel l s  in the treated group is  simi lar to that of 
normal contro l .  Magn i fi cation:  X400 
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Fi gure 44.  M i crographs of glucagon- imm unoreacti ve ce l ls  (arrow) in pancreatic  i s lets of diabetic rats . 
A .  Diabetic control . 
B .  Diabetic rats treated w i th C. colocynthis ( l mllkg of aq ueous extract) .  
C .  Diabetic rats treated with C. co 10 cynth is (2m l/kg of aqueous extract). 
D.  Diabetic rats treated with C. colocynthis (4mllkg of aq ueous extract). 
The number and pattern of d istribution of gl ucagon-positi ve cel ls  in the pancreatic i slets of rats treated w i t h  
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Figu re 46 : Effect of aqueous ex1ract of Cifrullus colocynthis on the percentage 
distribution of glucagons IInmunoreactive cel ls of fasted normal non-diabetic 
groups (Data are mean ± SO, n= 1 8-30). (Low dose=0.2Sml,  moderate 
dose=O .SmL hIgh dose= 1 mJ ). 0 .2SmJ of the plant ex1:ract induced slgmficant (* = 
p <0.00 1 )  increase in the percentage of glucagon immunoreactive cells compared 
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Figure 47: Effect of aqueous ex.1:ract of O frullu colocynthis on the percentage 
dIstribution of glucagon i mmunoreactive cel ls of fasted d iabetic groups (Data are 
mean ± SO, n=20-30). (Low dose=0.2SmJ,  moderate dose=O.Sml ,  high dose= l 
ml). O .SmJ, 1 mI of the p lant ex.1:ract induced significant ( * = p <0.03, * *  = p 
<0.002) increase in  the percentage of glucagon immunoreactive cells compared to 
control. 
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DIabetes IS posslbJ the world's fastest growmg metabolic disease. Whi l e  
the knowledge of the heterogeneity of this disorder increases, also the need for 
more appropriate therapies increases (Bai l ' and Flatt, 1 986). Traditional 
medicinal plants are used through out the world for a wide range of diabetic 
presentations. The stud of such m edicines might ofTer a natural ke to unlock a 
diabetologi t 's  pharmacy for the future (Abdel-Barry et ai, 1 997). 
I-In Vitro E x p e ri m en t 
Man local herbs, including Zygophyllum Simplex, Tephrosia apollinea. 
Teucrium mas atense. Rhazya stricta, Ziziphus spina-cnsti. Moringa peregrina. 
\vhich were considered to have anti-hyperglycaemic effect (EI-Ghonemy, 1 993, 
Ghazanfar, 1 994) fai led to stimulate insul in secretion from pancreatic tissue 
fragments. The reason for the i nabi lity of these plant extracts to evoke insulin 
release from the pancreas of normal rat is unknown. It is  possible that the 
hypergl, caemic effect of these plants may be initiated via a different mechanism 
such as inhibition of absorption of nutrients, improvement of the accessibi l ity of 
glucose target cells and insul in sensitivity. However, more studies are needed in 
this area to elucidate the mechanism by which these p lants initiate their beneficial 
effects in the treatment of diabetes mel l itus. Of all the plant extracts screened for 
their i nsul inotropic effects, only C itrullus colocynthis had a significant effect on 
increasing i nsul i n  secretion. 
The result of this study showed that different doses of the extract of Cifrullus 
colocynthis can evoke large and significant increases in i nsul in release from the 
pancreas of normal rats. This was observed at higher concentrations of the plant 
extract. This result corroborates with that of previous studies (Nmila  et aL 2000) on 
the effect of Citrullus colocynthis on insulin secretion. Different ex1:racts obtained 
from Citrullus colocynthis seeds were shown to stimulate insulin secretion in vitro in 
isolated perfused rat pancreas, in the presence of a sl ightly stimulating glucose 
concentration (Nrnila et aI, 2000). This effect is through a d irect action of the extract 
on endocrine pancreatic p-cel l s  (Nmila et aI, 2000). There are reports indicating that 
Citrullus colocynthis seeds contain one or several insul i notropic substances (Nmila et 
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al . ,  2000). Because of the beneficial effects of these insulinotropic substances in the 
seeds of Otrullus colocynth/s, it is widely used as a tradi tional medicine in Morocco 
and in the Arabia Peninsula for the treatment of diabetes mel l itus. In fact, this insulin  
stimulating effect could improve glucose-induced insul in secretion, thereby 
counteracting the deficiency of pancreatic cel l  which occurs in some types of non­
insul in dependent diabeti cases (Cerasi and Luft, 1 967·  Kahn and Porte, 1 988). This 
herb could be a cheaper alternative to expensive drugs used in the treatment of 
diabetes mel l itus. 
IJ.-In Vivo E x perim ent 
STZ selecti vel destro s the pancreatic islet cel Js  that secrete insulin, which 
causes less act ive pancreatic cel ls  and produces diabetes mell itus (peungvicha et aI, 
1 998). Oral administrat ion of aqueous extract of Citrullus colocynthis seeds for two 
weeks produced a statistical ly significant dose-correlate rising acti vity i n  plasma 
insul in level for both non-diabetic and diabetic rats. The phytochemical screening of 
Citrullus colocynthis revealed the presence of tertiary or quaternary alkaloids, 
glycosides, saponin in addition to other compound such as amino acids, proteins and 
tribines (Afifi et al , 1 973, Darwish et al, 1 974). The effect of the extract of Citrullus 
colocynthis seeds in increasing p lasma insul in may be due to a mix1:ure of amino acids 
such as leucine or iso-leucine, which are general ly known to stimulate insul in 
secretion when given either alone or in combination with each other (Fajans et al., 
1 972: Sener et al, 1 98 1 , 1 982). 
The results of this study showed that, the aq ueous extract of C. colocynthis 
has a s ignificant glucose-lowering effect in diabetic as wel l  as in non-diabetic rats. 
This effect could, possibly, be due to increased peripheral glucose util ization. 
Inhibition of the proximal tubular reabsorption mechanism for glucose in the kidney, 
i f  any, can also contribute towards blood lowering effect (Sharma et al, 1 983). Also, 
the oral hypogJycaemic effect of the aqueous extract of the C. colocynthis could be 
due to the presence of saponin components, which possess a strong hypoglycaemic 
effect (Abdel-Hassan et al, 2000). In addition, the effect of C. colocynthis may also be 
exerted indirectly through insul in. 
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At the end of this experiment the bod weight of normal and diabetIc rats ctid 
not Improve significant! after oral administration of the aqueous extract of C. 
colo ynthis . .  There \! ere no l iterature data on the effect of C. colocynthis on the 
weight of diabetes rats. Howeyer studies performed on diabetic rabbits showed that 
C colocynthl de reased the weight of diabetic rats (Abdel-Hassan et al. ,  2000). 
I I- I . B iochem ical  a n a lysis  
The effect of aqueous C colocynthis extract on potassium in fasted non­
diabetic groups was not significant. On other hand, in diabetic groups the potassium 
concentration was increased after treatment. It is weJ l known that diabetes mellitus 
causes an influx of potassium from cells into the extracel lular space. ill view of this, 
serum potassium is usually normal to sl ightly elevated in diabetes mellitus 
(Greenspan and Strewler. 1 997). The oral administration of the aqueous extracts of 
the C colocynthis fai led to cause significant changes in the plasma level of potassium 
compared to control .  This  may be due to the short duration of the experiment or the 
fact that biochemical and physiological parameters of diabetes mel l itus were not 
completely normalized. In a similar trend, the plasma level of sodium of normal and 
diabetic rats did not change significantly after the oral administration of the aqueous 
extract of C colocynthis. 
Liver enzymes used as markers for hepatotoxicity include the following 
AL T, AST, GGT, LDH and ALP. Serum AL T is thought to be a more specific 
indicator for l iver damage. The plasma level of ALT increased significantly after the 
onset of experimental d iabetes. ill contrast, the plasma level of AL T decreased 
significantly after the administration of the plant extract. All of these results raised 
and confirm a number of interesting issues. Firstly, that STZ has a hepatotoxic effect 
by increasing the plasma level of ALT and secondly, the aqueous extract of the C. 
colocynthis can ameliorate the toxic effect of STZ in the liver. Moreover, this study 
suggests that C co 10 cynth is is not toxic at least when given in the higher doses in this 
study. 
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GGT is an enzyme bel ieved to be in 01 ed in the transport of amino acids 
and pepudes into cel l s  as well as glutathione. Its elevation may be found in l iver 
disease or drug abuse. In diabetic rats there was a signi ficant i ncrease in plasma GGT 
level . This el e ation i s  an i ndicator of hepatotoxicity caused by STZ. There \ ere no 
signi ficant changes in the level of GGT even after treating diabetic rats with low and 
moderate doses of the aqueous extract of the plant. 
I ncrease in  creatinine Ie el was variable used not only to indicate 
impairment of kidney function (Braunlich et al, 1 997;  Hwang et aI, 1 997), but it 
helps to detect treatment related toxic effects of compounds on the kidney in rats 
(Tra ols et ai, 1 996). 
There was no signi ficant change in the concentrations of many other 
biochemical parameters (creatin ine, calcium, sodium, phosphorus) investigated . It 
is not known wh there were no changes in these biochemical parameters after 
treatment with the plant extract. It is possible that the concentration of the extract 
may be too weak to have a significant effect or the tissue or organ damage may be 
too severe to show an detectable improvement. 
II-2 . Morp hological investigations 
There were changes in the pattern of distribution of insulin and glucagon 
positiye cells  in pancreas of non-diabetic and diabetic treated animals compared to 
that of normal and diabetic control . The pattern of d istribution of endocrine cel ls i n  
normal pancreatic is lets followed a specific pattern i n  which insulin-producing cells 
were located in the central and peripheral parts of the islets. Glucagon-positive cells 
on the other hand were observed exclusively in the peripheral region of the islet of 
Langerhans. Our observation on the pattern of d istribution of these hormone-secreting 
cell s  is simi l ar to that reported previously (Adeghate and Donath, 1 99 1 )  
After the onset of diabetes, there was a gross derangement in the pattern of 
distrib ution of these p ancreatic peptides. The density of insulin positive cel ls became 
more sparse, leaving pancreatic islets with only a few surviving beta cells. This 
observation shows that STZ does not destroy al l of the beta cells in pancreatic islet i n  
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it total l , . This result corroborates those reported by Adeghate ( 1  999b). A total 
destruction of the beta ceUs in pancreatic islet wi l l  make l i fe completely unviable and 
surn al di fficult for the animals. Gl ucagon-containing ceUs occupied areas in both 
the central and peripheral portions of the is let of Langerhans, a feature not seen in 
normal pancreas. Moreover, morphometric i nvestigation suggests that the number of 
glucagon-positive cel ls  increased significantl when compared to normal, non­
diabetic rats. The increase in the number of glucagon-secreting cel l s  may contribute 
to the hyperglucagonaernia obsen'ed in diabetes. Hyperglucagonaernia is a constant 
feature of diabetes and has been impl icated in the pathogenesis of complications 
associated with d iabetes mel l itus. nus observation is in agreement with previous 
reports (Adeghate 1 999b). 
Oral administration of the aqueous extTact of C. c% cynthis appeared to 
have induced a significant increase in the number of insul in-immunoreactive cells  in 
the is let of Langerhans of diabetic rats. The mechanism by which the aqueous extracts 
of C. colocynth is causes i ncrease i n  the number of insuJin-positi e cel ls  in unknown. 
It is possible that the plant extract may help in the regeneration of pancreatic  beta 
cell s  damaged by STZ. It may also be involved in the production of new beta cells  
from progenitor cel ls  such as those in pancreatic duct.  Pancreatic beta cel ls have been 
to be present in the ducts of pancreas (Adeghate and Domith, 1 990). In addition, C. 
colocynthlS may also contain anti-oxidants that may neutral ize the destructive and 
tIssue-damaging effects o f  cytokines released by STZ during the induction of 
experimental d iabetes. It is known that the administTation of STZ wil l  induce a 
cascade of events during which many cytokines wi l l  be l iberated to destroy pancreatic 
beta cel ls in the is lets (Adeghate and Parvez, 2000). All of these indicate that that C. 
co!ocynthis has a regenerative effect on pancreatic beta cells. The abi l i ty of a plant 
extract to i ncrease the number of insulin-posit ive cel ls has been reported for 
Momordica charantia, (Ahmed et al. , 1 998) a plant in the same family as C. 
colocynthis. 
The results of this study suggest that the aq ueous extracts of C. colocynthis 
reduced the number of glucagon-positive cel ls  significantly when compared to 
control .  The mechanism by which aqueous extracts of C. colocynth is reduces the 
number of glucagon-positive cel ls is unknown, but this could be an indirect effect of 
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the relative mcrease in the number of insul in-positi e cel ls. The plant extract can thus 
reduce the severe hyperglucagonaemi a  b reducing the number of glucagon­
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